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 The purpose of this study was to compare the effects of a single session of 
exercise versus accumulated sessions of exercise on plasma lipid and lipoprotein 
concentrations.  Twelve young (22.5±2.5 years, mean±SEM), overweight (body mass 
index=29.7±3.9 kg.m-2), sedentary participants performed, in random order, a single 
exercise session (treadmill exercise at 60% maximal oxygen consumption for 90 
minutes), accumulated exercise sessions (the same protocol as above for three 
consecutive days), and a control session (no exercise for six consecutive days).  Blood 
samples taken immediately before each exercise/control session, and at 24, 48 and 72 
after exercise were analyzed for high-density lipoprotein cholesterol (HDL-C) and 
triglyceride (TG) concentrations.  Data were analyzed using a repeated measures 
ANOVA, based upon a priori analyses (i.e., pre versus post-exercise time points) both 
within and across protocols.  Significant interactions and main effects were analyzed 
using post-hoc paired samples T-tests.  Statistical significance was set at the 0.05 level. 
 The three exercise session protocol produced significant elevations in HDL-C 
concentrations 24 and 48 hours post-exercise, compared to the control.  Additionally, 
there was a significant time by trial interaction for HDL-C, with concentrations elevated 
at 48 hours post-exercise for the three exercise session protocol compared to the single 
session.  A significant percentage change reduction in TG concentration was observed 
after the three exercise session protocol compared to the control.  These results suggest 
that, in young, overweight, sedentary individuals, accumulating three consecutive 90-
 
 
 
 
 
 
 
minute sessions of exercise is more effective in improving plasma HDL-C and TG 
concentrations when compared to a single session of exercise.  In summary, these results 
support the additive benefits of exercise and justifies future exercise training studies 
aimed at determining the exact manner in which to accumulate exercise sessions (e.g., 
every day, every other day, etc.) in an effort to most effectively improve an individual’s 
lipid and lipoprotein profile.
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CHAPTER I 
 
INTRODUCTION 
 
 
Increased physical activity levels have been shown to reduce the risk of coronary 
artery disease (CAD).  However, due to the complexity of processes stimulated by 
physical activity, the exact metabolic mechanisms responsible for the reduced CAD risks 
have not been fully identified (Haskell, 1994).  Physical activity interventions, in the 
form of exercise training and single exercise sessions, have been shown to positively 
modify certain lipoprotein factors.  Specifically, plasma high density lipoprotein-
cholesterol (HDL-C) and triglyceride (TG) concentrations have been shown to be the 
most modifiable by exercise.  Also, research has not determined whether exercise training 
changes in HDL-C and TG are the result of an accumulation of effects from individual 
exercise sessions or mainly a result of the last session of exercise completed. 
Despite not having a precisely defined dose-response curve charting physical activity and 
CAD risk, professional organizations have implemented physical activity 
recommendations.  With the primary goal of improving overall health, adults are 
recommended to engage in at least 30 minutes of moderate intensity physical activity 
(e.g., 40-60% VO2max) on most days of the week (Pate et al., 1995; Haskell et al., 2007).  
However, the Institutes of Medicine (IOM) has recommended that sedentary adults 
attempting to lose weight should accumulate as much as 90 minutes of moderate intensity 
exercise every day (Brooks et al., 2004).  While many health-related benefits may be
 
2 
 
 
expected, the primary goal of the latter recommendation is to increase caloric 
expenditure.  Aerobically-trained individuals tend to exhibit anti-atherogenic blood lipid 
profiles compared to their inactive counterparts (Halbert et al., 1999; Thompson, 1990; 
Thompson, 1991).  There is limited longitudinal evidence to support exercise induced 
changes in total cholesterol (TCHL) and/or low density lipoprotein cholesterol (LDL-C) 
concentrations (Leon et al., 1996; Leon et al., 2002; Kraus et al., 2002; Nieman et al., 
2002).  Moreover, the majority of cross-sectional studies indicate smaller, non-significant 
differences for TCHL and LDL-C concentrations between exercise-trained and inactive 
individuals (Durstine and Haskell, 1994, Superko, 1991).  In contrast, both observational 
studies and randomized clinical trials provide stronger evidence for significantly reduced 
TG and elevated HDL-C baseline concentrations in physically active individuals 
(Durstine et al., 1994; Durstine et al., 2000; Halbert et al., 1999; Thompson, 1990).  
However, it is currently unknown what exercise “frequency” will produce the most 
prolonged and clinically significant TG and HDL-C concentration changes. 
Most exercise training studies resulting in improved HDL-C and TG 
concentrations have utilized training doses of 3-5 exercise sessions per week for 6-8 
months.  These findings are congruent with the traditional approach to the physical 
activity dose-response curve, which indicates multiple sessions of exercise must be 
performed over an extended period of time to be of benefit (e.g., reduced CAD risk) 
(Haskell, 1994).  However, an alternative hypothesis is that some of the blood lipid 
changes resulting from an exercise training program are due to the acute metabolic 
responses elicited both during and shortly after the most recent session of activity.  Few 
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studies to date have analyzed the effects of aerobic exercise training (i.e., a possible 
accumulated or additive effect) compared to a single session of physical activity 
regarding exercise-induced blood lipid changes.  Fully defining the effects of 
accumulating sessions of exercise will constitute an important step in determining an 
optimal exercise frequency for favorable alteration of one’s blood lipid profile. 
It has been demonstrated in numerous investigations that a single session of 
exercise can result in acute lipid and lipoprotein modifications (Ferguson et al., 1998; 
Gordon et al., 1998; Grandjean et al., 2000; Jafari et al., 2003; Park and Ransone, 2003; 
Thompson et al., 2001; Wooten et al., 2008).  Similar to exercise training, single sessions 
of exercise appear to primarily modify HDL-C and TG concentrations.  These studies 
have included various exercise modes, intensities and durations.  However, few studies to 
date have analyzed the effect of accumulating single sessions of exercise.  For example, it 
is unknown if exercise performed on a day-to-day basis is more beneficial than exercise 
performed every other day.  Examining the effect of accumulated daily exercise sessions 
can lead to an eventual definition of the most effective exercise regimen [i.e., frequency 
of exercise (everyday versus every other day, etc.)] for improving one’s plasma lipid 
profile.  This will result in more accurate exercise recommendations for optimally 
reducing an individual’s risk for cardiovascular disease (CVD). 
Although professional organizations have produced physical activity 
recommendations, the amount and timing (i.e., duration per session and time between 
each exercise session) of physical activity required to optimally elevate HDL-C and 
reduce TG plasma concentrations has not been determined.  As a first step in addressing 
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this problem, the purpose of the proposed dissertation was to investigate the effects of a 
single session of exercise versus the potential additive effect of three sessions of exercise 
on the blood lipid profiles of young, sedentary men and women.  Results from this study 
will provide important baseline information for future investigations assessing more 
specific components of exercise prescription (i.e., frequency, caloric expenditure/exercise 
time, etc.) in an effort to decrease CVD risk. 
 
Purpose of the Study 
 
 The purpose of the study was to compare the effects of a single session of 
exercise versus accumulated sessions of exercise on plasma lipid and lipoprotein 
concentrations in young, sedentary obese participants. 
 
Specific Aims 
 
The Specific Aims of this investigation are as follows: 
1. To compare the effects of a single 90-minute treadmill exercise session performed 
at 60%VO2max versus no exercise (control group) on lipid and lipoprotein 
concentrations in young, sedentary obese adults. 
Working Hypothesis (a):  A single session of exercise will produce improved 
 plasma  
triglyceride concentrations 24-72 hours post-exercise compared to the control 
 group. 
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Working Hypothesis (b):  A single session of exercise will produce improved 
 plasma  
HDL-C concentrations 24-72 hours post-exercise compared to the control group. 
2. To compare the effects of three 90-minute treadmill exercise sessions performed 
at 60% VO2max (completed on consecutive days) versus no exercise (control 
group) on lipid and lipoprotein concentrations in young, sedentary obese adults. 
Working Hypothesis (a):  Three consecutive days of exercise will produce 
improved plasma triglyceride concentrations 24-72 hours after the last session of 
exercise compared to the control group. 
Working Hypothesis (b):  Three consecutive days of exercise will produce 
improved plasma HDL-C concentrations 24-72 hours after the last session of 
exercise compared to the control group. 
3. To compare the effects of a single 90-minute treadmill exercise session performed 
at 60%VO2max versus three 90-minute exercise sessions performed at 60% VO2max 
(completed on consecutive days) on lipid and lipoprotein concentrations in young, 
sedentary obese adults. 
Working Hypothesis (a):  Three consecutive days of accumulated exercise will 
produce a greater improvement in plasma triglyceride concentrations 24-72 hours 
after the last session of exercise compared to the improvement in plasma 
triglyceride concentrations 24-72 hours after a single session of exercise. 
Working Hypothesis (b):  Three consecutive days of accumulated exercise will 
produce a greater improvement in plasma HDL-C concentrations 24-72 hours 
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after the last session of exercise compared to the improvement in plasma HDL-C 
concentrations 24-72 hours after a single session of exercise. 
 
Significance of the Study 
 
 It has not been determined whether the favorable blood lipid and lipoprotein 
changes observed with exercise training occur as an accumulation of small effects from 
individual exercise sessions, or if the “training” effect is primarily a result of the last 
session of exercise completed.  This study attempted to clarify the difference between the 
stimulatory effects of a single session versus accumulated sessions of exercise on blood 
lipid and lipoprotein concentration changes.  The accumulated sessions of exercise (3 
consecutive days of treadmill exercise at 60%VO2max for 90 minutes) were expected to 
simulate a short-term exercise training effect.  The post-exercise effects of this exercise 
training protocol will be compared to the post-exercise effects of a single session of 
exercise (90 minutes of treadmill exercise at 60%VO2max).  These data will aid future 
investigations assessing more specific components of exercise prescription (i.e., 
frequency, caloric expenditure, etc.) in an effort to decrease CVD risk. 
 
Limitations 
 
1. Volunteers served as subjects and, therefore, did not make up a random sample. 
2. Total caloric output for each experimental exercise session did differ slightly.  
Although specific caloric expenditure was not assigned for each exercise session, it 
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was calculated from expired gases.  Also, this study investigated a published physical 
activity recommendation that was based upon time rather than caloric expenditure. 
3. Dietary intake was not directly controlled.  However, subjects completed three day 
dietary intake logs prior to each experimental exercise protocol and maintained 
dietary logs throughout each day of all three protocols. 
4. Failure of subjects to comply with the instructions of the researchers to refrain from 
exercise during the week/weeks in between experimental protocols may have 
produced variability in the results.  However, only physically inactive subjects were 
recruited.  As >300 kcal of energy expenditure is typically needed to elicit significant 
acute changes in plasma lipids, it was unlikely that any impulsive physical activity 
would have been sufficient to alter the results of this study (Grandjean et al., 2001). 
 
Delimitations 
1. Twelve apparently healthy males and females between the ages of 18-30 years, who 
were non-smokers (also not using tobacco products), did not drink more than an 
average of 2 alcoholic beverages per day, and did not use lipid altering medications, 
were recruited as subjects (as smoking, alcohol consumption, and lipid altering 
medications could have affected blood lipid concentrations independent of any 
exercise induced changes).  Young subjects were recruited due to a higher likelihood 
of being able to complete the required 90 minutes of exercise per session on three 
consecutive days. 
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2. Subjects were tested following a 12 hour fast to minimize dietary effects on blood 
lipid and lipoprotein concentrations. 
3. Subjects were not engaging in any abnormal and/or significant physical activity 
during the time periods between exercise protocols. 
4. Subjects performed a single session (treadmill exercise 60% VO2max for 90 minutes), 
accumulated sessions (three consecutive treadmill sessions 60% VO2max for 90 
minutes), and control session (no exercise for six consecutive days), respectively, in a 
random crossover design.
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CHAPTER II 
REVIEW OF LITERATURE 
 
 
Introduction 
 Coronary heart disease (CHD) is the leading cause of death (about 35% of all 
deaths) in the United States (Gordon et al., 1998; Jafari et al., 2003).  However, over the 
past few decades, a substantial body of evidence has demonstrated an inverse relation 
between physical activity and CHD risk.  In response, many professional organizations 
have recommended that all adults should accumulate at least 30 minutes of moderate-
intensity physical activity on most, if not all, days of the week.  However, there is 
compelling evidence that obese individuals attempting to lose weight should perform 90 
minutes of moderate intensity activity (Brooks et al., 2004).  While it is well documented 
that regular physical activity reduces CHD risk, research has not defined the mechanisms 
responsible for this cardioprotective effect. 
While all mechanisms for CHD risk are not defined, the beneficial effects of 
physical activity may be, partially, due to modified blood lipids and lipoproteins 
(Durstine, 2001).  Independent of other major cardiovascular risk factors, observational 
studies suggest that physically active individuals tend to exhibit an anti-atherogenic blood 
lipid profile when compared to their inactive counterparts (Durstine et al., 2001; Pate et 
al., 1995).  Experimental data suggests that the favorable blood lipid profiles of 
physically active individuals are primarily due to increased HDL-C and reduced TG 
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concentrations (Halbert, 1999; Grandjean, 2000; Crouse, 1999; Kraus, 2000).  These 
blood lipid and lipoprotein modifications are, within limits, based upon a dose-response 
relationship. 
This dose-response relationship suggests that as the dose of physical activity 
increases the beneficial response of plasma lipid and lipoproteins will also increase.  
Exercise dose is generally defined as the type, intensity, and duration of physical activity 
required to produce plasma lipid benefits.  However, the exact dose of physical activity 
required for the most optimal blood lipid and lipoprotein response has not been defined.  
Also, the most optimal frequency (i.e., time allotted between exercise sessions) in which 
to perform the exercise dose has not been determined (Durstine and Haskell, 1994).  
Since blood lipid concentrations can be transiently (i.e., 24-72 hours) altered after one 
exercise session it is important to assess exercise frequency.  It is not only a matter of 
how many times per week exercise should be performed, but how much time should be 
allotted between each exercise session.  Therefore, in order to properly produce a more 
optimal blood lipid response it is vital that all aspects of exercise frequency (i.e., days per 
week and time between each exercise session) be fully defined.  A more thorough 
understanding of how daily exercise accumulation affects short-term blood lipid 
concentrations will aid in producing more optimal long-term exercise prescriptions, 
thereby decreasing CVD risk.  
This chapter presents a review of related literature in the area of blood lipid and 
lipoprotein changes produced from exercise.  It is organized into the following sections: 
Cholesterol Transport, Effects of Physical Activity on Lipoprotein Metabolism, Aerobic 
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Exercise Training, Single-Sessions of Exercise, and the Acute Augmented Exercise 
Response. 
 
Cholesterol Transport 
The movement of cholesterol and lipids throughout the body is primarily 
conducted by lipoprotein particles.  A lipoprotein is defined as a globular biochemical 
assembly containing both lipids and proteins.  The outer core, or “shell”, of the structure 
is composed of phospholipids and apolipoproteins.  These components allow the 
lipoprotein to be water-soluble and aid in determining the action and core content of the 
lipoprotein.  The core is composed of lipid, primarily in the form of triglyceride (TG) and 
cholesteryl ester (CE).  All cells of the body require both TG and CE for normal 
metabolic functions.  Most lipoproteins carry TG and CE to peripheral cells, while other 
lipoproteins carry TG and CE away from peripheral cells.  These two transport systems 
maintain a homeostasis for TG and CE concentrations within the blood stream. 
 This homeostatic environment is maintained via two separate lipoprotein transport 
systems which work together.  The forward cholesterol transport system (FCT) transports 
both exogenous (i.e., dietary intake) and endogenous (i.e., liver production) lipids to the 
liver and peripheral tissue.  The reverse cholesterol transport (RCT) system transports TG 
and CE back to the liver for catabolism.  Table 1 provides a full list of the apolipoproteins 
for both the forward and reverse cholesterol transport systems (Davis and Wagganer, 
2005). 
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Table 1 
Apolipoproteins 
 
Apolipoprotei
n 
Site of 
Synthesis 
Associated 
Lipoprotein Function 
Apo A-I Liver, Intestine Chylomicron, HDL 
Structural protein for HDL. 
Cofactor for LCAT. Ligand 
for putative HDL receptor. 
Apo A-II Liver HDL 
Inhibits Apo-E binding to 
receptors (through the E-
AII complex.) 
Apo A-IV Intestine Chylomicron, HDL 
May facilitate cholesterol 
efflux from cells.  Activator 
of LCAT. 
Apo B-100 Liver VLDL, IDL, LDL 
Structural protein for 
VLDL and LDL. Ligand for 
LDL receptor. 
Apo B-48 Intestine Chylomicron Structural protein. 
Apo C-I Liver VLDL, HDL 
Modulates remnant binding 
to receptors. Activates 
LCAT. 
Apo C-II Liver 
Chylomicron, VLDL, 
HDL Cofactor for LPL. 
Apo C-III Liver 
Chylomicron, VLDL, 
HDL 
Modulates remnant binding 
to receptors 
Apo E2 
Liver, brain, 
skin, 
testes, 
spleen 
Chylomicron, VLDL, 
HDL 
Ligand for LDL receptor. 
Preferentially bind with 
HDL. 
Apo E3 
Liver, brain, 
skin, 
testes, 
spleen 
Chylomicron, VLDL, 
HDL 
Ligand for LDL receptor. 
Preferentially bind with 
HDL. 
Apo E4 
Liver, brain, 
skin, 
testes, 
spleen 
Chylomicron, VLDL, 
HDL 
Ligand for LDL receptor. 
Preferentially bind with 
VLDL. 
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Forward Cholesterol Transport 
 It is well understood that cholesterol is involved in several biologic processes.  In 
normal biological processes cholesterol is primarily synthesized by the liver, with smaller 
portions coming from other various bodily tissues.  Along with this internal synthesis, 
cholesterol can also be obtained from exogenous (e.g., dietary) sources.  Cholesterol 
functions as a stabilizing component for the cellular membranes of all body cells and acts 
as a major precursor in the production of steroid hormones. 
The dietary intake of lipid generally consists of TG, which are three long-chain 
fatty acids attached to a glycerol backbone.  These fatty acids pass through the digestive 
track, where they are eventually absorbed by the small intestine.  The small intestine 
packages these fatty acids into a large lipoprotein micelle called a chylomicron.  The 
outer surface is naturally hydrophilic consisting of phospholipids (9%), cholesterol (3%) 
and apolipoproteins (1%) with the core content of TG (86%) and CE (1%) (Hussain, 
2005; Hultin and Olivecrona, 1998).  The outer shell of the chylomicron contains 
apolipoprotein B-48, apo C-II, apo E, and apo A-1.  Apolipoprotein B-48 is the only 
apolipoprotein formed in the small intestine.  The general functions of these 
apolipoprotein’s are to stabilize and identify the chylomicron in circulation.  The density 
of a chylomicron is low because it is very large (>100nm) and has a high core lipid 
content (especially buoyant triglycerides). 
 Chylomicrons are too large to penetrate the capillary membrane; therefore they 
are secreted into the lymphatic system and enter the bloodstream by way of the thoracic 
duct.  Once in the blood, chylomicrons acquire apo E and apo C-II and are progressively 
 
14 
 
 
reduced in size by the action of lipoprotein lipase (LPL), which is bound to the surface of 
capillary endothelial cells and catalyzes the removal of free fatty acids from the 
chylomicron triglyceride pool (Cooper, 1997).  LPL is activated by the presence of apo-
CII on the outer “shell” of the chylomicron.  While LPL can hydrolyze triglycerides from 
any lipoprotein particles, it primarily acts upon chylomicrons and very-low-density 
lipoproteins (VLDL) due to their high TG content and the presence of apo-CII.  The 
action of LPL hydrolyzing TG from the core of the chylomicron also causes surface 
fragments of the outer shell to break off and be transferred to maturing HDL particles.  
Primarily apo A-1 ligands from the chylomicron will be transferred to HDL particles, 
benefiting the RCT system.   
The fatty acids released by the action of LPL can be utilized by peripheral tissues 
as an energy source or stored intracellularly as a triglyceride for later use.  The action of 
LPL will quickly deplete the chylomicron TG content producing a smaller chylomicron 
remnant.  These chylomicron remnants are taken up by hepatocytes through a receptor-
mediated process, with apo E serving as the primary binding ligand (Hultin and 
Olivecrona, 1998; Redgrave, 2004; Rustaeus et al., 1999).  The two primary liver 
receptors responsible for chylomicron remnant clearance from the blood are LDL 
receptors (LDL-R) and LDL receptor-related proteins (LRP).  While both receptors 
contribute to chylomicron remnant clearance, the LDL-R is normally predominant 
(Redgrave, 2004).  This entire process occurs quickly, which is why chylomicrons and 
their remnants are generally only observed in postprandial plasma samples. 
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The endogenous cycle of the FCT system begins with the hepatic production of 
lipoprotein particles containing TG and cholesterol.  The production of VLDL’s is 
stimulated by an increased delivery of free fatty acids (e.g., high intake of dietary fat) to 
hepatocytes.  Triglycerides and phospholipids to be used in the formation of VLDL are 
synthesized in the liver, whereas VLDL cholesterol can be synthesized de novo or 
reutilized from LDL particles (discussed below).  Acyl coenzyme A: cholesterol 
acyltranferase (ACAT), is believed to be the primary hepatic enzyme responsible for the 
production of VLDL molecules (Shelness and Sellers, 2001).  ACAT, located at the 
endoplasmic reticulum, acts to esterify free cholesterol delivered to the liver by other 
lipoproteins.  The cholesteryl esters produced by the action of ACAT can be stored for 
later use (intracellular cholesteryl ester pool), or packaged with triglycerides, 
phospholipids and an apo-B100 protein to form a VLDL particle (Shelness and Sanders, 
2001). 
The major protein constituent of VLDL is Apo B-100, with smaller amounts of 
apo-E and apo-C proteins.  The apo B-100 ligand functions in VLDL to mediate binding 
with the LDL-R.  Although apo B-100 is also a constituent of intermediate density 
lipoprotein (IDL) molecules, it does not appear to play a major role in the binding of IDL 
to LDL-R.  Similar to the chylomicrons, the apo-E ligands are primarily responsible for 
most of the receptor-mediated clearance of VLDL and IDL.  VLDL particles have two 
potential fates: receptor-mediated endocytosis or conversion to LDL particles.  Both are 
determined by the apolipoproteins of the VLDL particle and the presence of plasma 
lipases.  Approximately half of the apo-E enriched VLDL particles will be taken up by 
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LDL-R endocytosis.  The other half will be converted to LDL particles through the action 
of plasma lipases (Havel, 1984; Shelness and Sellers, 2001). 
The TG content of VLDL particles are primarily hydrolyzed by the action of LPL 
and hepatic lipase (HL).  As previously discussed, LPL is located on the capillaries of 
endothelial cells.  As the VLDL particle comes in contact with the endothelial cells, LPL 
hydrolyzes the TG content causing the VLDL particle to shrink in size.  HL is a member 
of the same TG lipase gene family as LPL and is synthesized primarily by hepatocytes.  
This lipase stays localized to the hepatic sinusoid capillaries bound to heparin-sulfate 
proteoglycans (HSPG) (Wang and Briggs, 2004).  HL primarily hydrolyzes triglycerides 
and phospholipids in VLDL and IDL, leading to the production of LDL particles (Jin et 
al., 2002).  HL can further hydrolyze LDL generating a smaller, more dense particle.  
While HL may produce a small, dense LDL particle, which is considered to be more 
atherogenic, it also positively alters the RCT system.  The interaction of HL with HSPG 
has been shown to be involved with the uptake of HDL cholesteryl esters by scavenger 
receptor class-B type I (SR-BI) located on the liver (Lambert et al., 1999).  The 
hydrolysis of triglyceride-rich HDL2 by HL generates a lipid-poor pre-B HDL particle 
that recirculates in the RCT system.  Based upon past research it appears that HL 
primarily acts to benefit the RCT system, however it does affect the FCT system as well 
(Jansen et al., 2002).  The continuous action of plasma lipases will cause the VLDL to 
become smaller and smaller, eventually being transformed into an IDL particle. 
 IDL particles are typically recognized as a “transition” lipoprotein in the 
conversion of VLDL to LDL.  IDL particles still retain the apo B-100 and apo-E 
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constituents but have lost most of the apo-C proteins.  The apo-E ligand, not the apo B-
100, of the IDL particle primarily acts to strongly bind the particle to LDL-R, clearing the 
particle from plasma.  While some IDL particles are cleared via receptor mediated 
endocytosis, most of the particles stay in the blood stream where LPL and HL continue to 
hydrolyze core triglycerides.  Both VLDL and IDL particles are rapidly cleared (e.g., 
half-life of minutes to a few hours) from plasma due to their high binding affinity to 
LDL-R (Takashi et al., 2004; Rustaeus et al., 1999) and the rapid hydrolysis action of 
LPL and HL (Havel and Kane, 1995). 
 LDL particles are the end products of lipase-mediated hydrolysis of VLDL 
particles and transport the majority of total plasma cholesterol (i.e., ~70%) (Rapp, 2002).  
Moreover, as the triglyceride-rich core of the larger VLDL particles is hydrolyzed by 
LPL and HL, the surface lipids and proteins are also remodeled.  The majority of outer 
shell protein constituents are transferred to HDL particles, producing a small, cholesterol 
rich LDL particle devoid of almost all apolipoproteins except apo B-100 (Havel, 1984).  
While some peripheral tissues are able to take up small amounts of LDL, the majority is 
metabolized by the liver via LDL-R (Rapp, 2002).  Unlike VLDL and IDL, the LDL 
particle does not have any apo-E constituents.  The primary protein constituent of LDL 
particles is apo B-100, which has a lower affinity for LDL receptors than apo-E 
(Schneider, 1991).  Due to this poor binding affinity, the half-life of LDL particles is 
approximately 2 to 3 days.  Thus, the difference in the affinities of apo B-100 and apo-E 
plays a role in plasma cholesterol homeostasis.  Figure 1 demonstrates the mechanisms 
involved in FCT. 
 
18 
 
 
Figure 1 
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Forward Cholesterol Transport. Dietary lipid is secreted from the small intestine in 
chylomicron particles.  The triglyceride content of the chylomicron is hydrolyzed by the 
action of lipoprotein lipase (LPL).  Free fatty acids (FFA) are taken up by peripheral 
tissues while the smaller chylomicron remnants are catabolized by both the hepatocyte 
low-density lipoprotein (LDL) receptor (LDL-R) and the LDL receptor-related protein 
(LRP) mainly through recognition of apolipoprotein (apo) E.  The endogenous hepatic 
production of lipid is primarily packaged in very low-density lipoprotein (VLDL).  The 
VLDL particle is reduced to an IDL particle via the action of LPL.  The IDL particle is 
subsequently reduced to an LDL particle by the actions of LPL and hepatic lipase (HL).  
Hepatic catabolism of the LDL particle primarily occurs through apo-B100 recognition 
by the LDL-R.  The major apolipoproteins associated with each particle are indicated and 
their characteristics and functions are listed in Table 1 (Davis and Wagganer, 2005). 
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 While the primary function of LDL is to transport cholesterol to the liver for 
catabolism, metabolic problems can occur when plasma LDL concentrations are elevated.  
Plasma LDL concentrations can become elevated 1) due to an insufficient number of 
hepatic LDL receptors, 2) the receptors do not possess proper affinity for the apo B 
ligand of the LDL particle, or 3) when dietary fat intake is high (causing LDL receptor 
synthesis to be down-regulated) resulting in elevated plasma cholesterol concentrations 
(Kwiterovich, 2000).  This excess of plasma cholesterol can induce and promote 
endothelial injury, inflammation, and ultimately the development of atherosclerosis.  
Specifically, the excess cholesterol carried by LDL can be internalized by macrophages 
in the vascular intima by scavenger receptors.  When the LDL particle enters the arterial 
wall it is oxidized, which increases its affinity to macrophage scavenger receptors.  These 
scavenger receptors can then be transformed into foam cells which secrete growth factors 
that stimulate the proliferation and migration of smooth-muscle cells, resulting in the 
formation of an atherosclerotic lesion.  Hence, excess cholesterol depositions from 
circulating sources (e.g., LDL particles) are currently believed to be the most frequent 
contributing factor for the development of atherosclerosis. 
 
Reverse Cholesterol Transport 
 All cells of the body require cholesterol for the synthesis and maintenance of cell 
membranes.  However, body cells do not possess an analogous (i.e., catabolic) 
mechanism for the metabolic disposal of cholesterol.  This is problematic because 
research indicates cholesterol may be atherogenic in vascular wall cells at some 
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physiological level and of exposure and is outright cytotoxic at higher levels (Tulenko et 
al., 2002).  Therefore, the metabolic balance of cholesterol is accomplished by the RCT 
pathway.   The RCT pathway functions to extract accumulated cholesterol from 
atherosclerotic plaque (and extrahepatic tissues, as well), and deliver it back to the liver 
for elimination as bile salts or biliary cholesterol.  The delivery of cholesterol to the liver 
is primarily performed by HDL particles, which have been shown to protect against 
atherosclerosis (Fielding and Fielding, 1995; Leaf, 2003; Masson et al., 2008; Rader, 
2003).  The entire RCT pathway involves the availability and interaction of 
apolipoproteins, enzymes, transfer proteins, and receptors. 
 The formation of HDL particles involves the accumulation of lipid-poor apo A-I 
particles, which originate from three major sources (Fielding and Fielding, 1995).  First, 
the liver secretes an apo A-I phospholipid disc called nascent HDL.  Second, the intestine 
directly synthesizes a small apo A-I containing HDL particle.  Third, small HDL discs are 
derived from excess material shed from chylomicrons and VLDL as they are hydrolyzed 
by LPL (Ribalta et al., 2003).  Apo A-I is essential for various cellular activities including 
the correct assembly and overall stability of HDL particles (Rye and Barter, 2004; Wang 
and Briggs, 2004), activation of the enzyme lecithin: cholesteryl acyltransferase (LCAT) 
(Sviridov et al., 2000), and the binding of phospholipid transfer protein to HDL particles 
(Huuskonen et al., 2001).  Most of the nascent or immature apo A-I immediately begin 
removing free cholesterol and phospholipids from peripheral tissues including 
atherosclerotic plaque (Wang and Briggs, 2004).  This process of lipid transfer from the 
plasma membrane of cells to apo A-I containing lipoproteins (e.g., small and large HDL 
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particles) is mediated by the cell membrane transporter ATP-binding cassette transporter 
1 (ABCA1) (Tall, 2008).   
Both immature and more mature forms of HDL particles primarily obtain free 
cholesterol and phospholipids via ABCA1.  However, the immature HDL particle has the 
ability to freely transverse the endothelium, making it the major acceptor of cholesterol 
and phospholipids from peripheral cells and atherosclerotic plaque formations (Tulenko 
et al., 2002).  As the HDL particle becomes more mature (i.e., spherical) it has the ability 
to obtain lipids from other lipoproteins in circulation (Wang and Briggs, 2004; Sviridov 
and Nestel, 2002).  The free cholesterol on the surface of the lipidated apo A-I is 
esterified by lecithin: cholesteryl acyltransferase (LCAT) (Sviridov et al., 2000). 
LCAT is a soluble enzyme primarily synthesized by the liver and activated in the 
plasma by the presence of apo A-1.  As the apo A-I esterifies free cholesterol it will begin 
to mature and grow into a more disc-like shape, generally called a preB2-HDL (Mahley et 
al., 1984; Sviridov and Nestel, 2002).  This growth occurs because the esterification of 
the free cholesterol with a long-chain fatty acid decreases its hydrophilicity, and the 
newly formed cholesteryl esters move away from the surface of the disc into the core of 
the lipoprotein.  As the core of the disc fills with cholesteryl esters it will change into a 
more mature and spherical shape.  Therefore, LCAT plays a pivotal role in promoting 
cholesterol efflux from peripheral cells to HDL after the initial cholesterol efflux 
mediated by ABCA1 to apo A-I, through which cholesterol molecules enter the RCT 
pathway. 
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The small, spherical mature HDL particles produced from the esterification of 
free fatty acids are called HDL3 particles.  As more free cholesterol is accepted and 
esterified the HDL3 particle will grow in size to form an HDL2 particle.  Therefore, the 
HDL3 particle will have a more triglyceride-rich core, while the HDL2 particle will 
possess a more cholesteryl-ester rich core.  These two particles can quickly be converted 
back and forth, primarily due to the action of cholesteryl ester transfer protein (CETP) 
and secondarily due to HL (described above) and endothelial lipase (EL).  The primary 
action of CETP facilitates the transfer of cholesteryl esters from HDL to lower-density, 
more triglyceride-rich lipoproteins (e.g., VLDL, IDL, LDL, and chylomicron remnants). 
CETP is a glycoprotein that is primarily secreted by the liver, and then binds to 
HDL particles in the blood stream.  The basic function of CETP is to elicit the 
redistribution of triglycerides and cholesteryl esters, and, to a lesser extent, phospholipids 
between plasma lipoproteins.  This redistribution primarily occurs by transferring 
cholesteryl esters from HDL2 particles to triglyceride-rich lipoproteins in exchange for 
triglycerides.  As the HDL2 particle losses cholesteryl esters and gains triglyceride 
content it will shrink in size and density, eventually becoming an HDL3 particle.  The 
HDL3 particle will begin esterifying free cholesterol from extrahepatic tissues until it 
once again gains enough size and density to be classified as an HDL2.  The cholesteryl 
esters moved from the HDL particles to triglyceride-rich lipoproteins is delivered back to 
the liver for metabolism.  Therefore, CETP acts to provide an indirect pathway by which 
HDL cholesteryl esters (i.e., esterified extrahepatic free cholesterol) are delivered to the 
liver and removed from the bloodstream. 
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As previously mentioned, EL also plays a role in HDL metabolism.  This lipase 
shares a similar identity to both LPL and HL.  However, unlike LPL and HL, EL is 
synthesized by endothelial cells and functions at the site where it is synthesized.  
Compared to LPL and HL, EL is more active in hydrolyzing HDL lipids, in particular 
phospholipids, generating free fatty acids (McCoy et al., 2002; Badellino and Rader, 
2004).  EL primarily shows phospholipase activity and relatively little triglyceride lipase 
activity (Borggreve et al., 2003).  Therefore, it is possible that EL is a physiological 
regulator of HDL metabolism, but more research is needed in this area to characterize its 
exact role. 
At this point in the RCT system it is important to discuss the role of phospholipid 
transfer protein (PLTP), which also possesses the ability to mediate the exchange of 
products between the FCT and RCT pathways.  It is synthesized in various tissues of the 
body (e.g., liver, lungs, and adipose tissue), however its main source in human plasma is 
unknown (Eckardstein et al., 1996).  PLTP facilitates phospholipid and free cholesterol 
transfer between lipoproteins during lipolysis (Albers and Cheung, 2004), and is believed 
to promote cholesteryl ester transfer toward TG-rich lipoproteins (Borggreve et al., 
2003).  It is also believed to play a role in the conversion of HDL into larger and smaller 
particles (i.e., HDL remodeling) (Huuskonen et al., 2001).  During this remodeling 
process, pre B-HDL particles are produced that act as initial acceptors of free cholesterol 
from peripheral tissues (Eckardstein et al., 1996; Huuskonen et al., 2001).  Both the lipid 
transfer and HDL remodeling processes of PLTP are believed to aid in the indirect 
pathway of the RCT system. 
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This indirect pathway of cholesterol removal is just one aspect of the RCT 
system.  As previously mentioned, the primary precursor for the formation of HDL 
particles is the apo A-I protein.  Apo A-I has a strong affinity to the SR-BI located on the 
cell surface of the liver.  Specifically, the SR-BI prefers the apo A-I associated with 
spherical, more mature HDL particles (e.g., HDL3 and HDL2) as opposed to the apo A-I 
found in preB2-HDL (Liadaki et al., 2000).  Therefore, some mature HDL particles will 
bind with the SR-BI, which selectively takes up cholesteryl esters located within the HDL 
particle.  This will act to shrink the size and density of the particle until it is released and 
allowed to re-circulate in the blood stream once again.  The particle can then start the 
entire process again, collecting free cholesterol and potentially circulating back to the 
SR-BI for cholesteryl ester clearance from the blood stream.  This is generally considered 
to be a more direct pathway for the delivery of cholesterol to the liver for metabolism; 
however both the indirect (as described above) and the direct pathway comprise the entire 
RCT system.  Figure 2 demonstrates the mechanisms involved in reverse cholesterol 
transport. 
 
Effects of Physical Activity on Lipoprotein Metabolism 
 Physical activity can be defined as bodily movement performed by the contraction 
of large muscle groups, which results in energy expenditure beyond resting energy 
requirements.  The general benefits of habitual physical activity include increased 
exercise capacity, endurance, and muscle strength.  While physical activity has many 
healthful benefits, epidemiological studies have shown that it may prevent, and help treat, 
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Figure 2 
Reverse Cholesterol Transport         
HDL3
LCAT
TG CE
LCAT
HDL2
CE TG
TG
CE
SR-BI
TG-rich 
lipoproteins
CETP
Liver
preß2-HDLpreß1-HDL
Peripheral 
Tissue or 
Macrophage: 
FC / PL
ABCA1
AA
 
             
Reverse Cholesterol Transport.  Lipid-poor pre-beta1 high-density lipoprotein (pre-ß1 
HDL), composed primarily of apolipoprotein (apo) A-I acquires free cholesterol (FC) and 
phospholipids (PL) from peripheral tissue or arterial macrophages.  This efflux process is 
facilitated by the cellular protein adenosine triphosphate-binding cassette protein A1 
(ABCA1) and allows the pre-ß1 HDL particle to take on a more discoidal shape.  
Esterification of cholesterol in pre-ß2 HDL by lecithin-cholesterol acyltransferase (LCAT) 
leads to the formation of spherical HDL3 particles.  The continued action of LCAT 
transforms HDL3 particles into larger, more cholesterol-rich HDL2 particles.  Cholesteryl 
ester transfer protein (CETP) facilitates the transfer of CE from HDL to triglyceride 
(TG)-rich lipoproteins in exchange for TG.  Adding and removing CE to/from HDL, 
LCAT and CETP, respectively, cause HDL particles to be in constant flux between HDL2 
and HDL3.  Hepatic catabolism of HLD primarily occurs through apo A-I and apo A-II 
recognition by the scavenger receptor B-I (SR-BI) (Davis and Wagganer, 2005). 
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many of the risk factors associated with the development of coronary artery disease 
(CAD) (Durstine et al., 2001).  This cardioprotective effect may be partially explained by 
a favorable influence on plasma lipid and lipoprotein concentrations (Durstine and 
Haskell, 1994; Welk and Blair, 2000).  It has been suggested that the demands of exercise 
modify the action of lipid regulatory enzymes and transfer proteins, producing post-
exercise changes in plasma lipid and lipoprotein concentrations.  The enzymes and 
transfer proteins most often implicated in this beneficial effect on lipid metabolism 
primarily include LPL and HL, with a smaller emphasis on LCAT and CETP. 
LPL is a rate-limiting enzyme for the catabolism of triglyceride-rich lipoproteins 
and its action is believed to be directly modified by muscular activity levels (Leaf, 2003).  
Current data suggests that even a small increase in physical activity (i.e., slow treadmill 
walking compared to physical inactivity) can beneficially increase muscle LPL activity, 
independent of gender (Perreault et al., 2004; Bey & Hamilton, 2003; Tall, 2002).  More 
specifically, an acute bout of moderate intensity exercise increases muscle tissue LPL 
more than adipose tissue LPL (Grandjean et al., 2000; Lambert et al., 1999; Thompson et 
al., 2001; Seip et al., 1993).  The prevailing thought is that muscular contractions 
associated with acute exercise act to deplete intramuscular triglyceride (IMTG) stores, 
which stimulates the production and secretion of muscle tissue LPL (Durstine and 
Haskell, 1994; Thompson, 1991; Zderic & Hamilton, 2006).  The increased LPL moves 
to endothelial cells in capillary beds of muscle tissue where it will hydrolyze more 
triglycerides from VLDL and chylomicrons in order to restore the IMTG stores (e.g., 
those depleted during exercise).  While this may restore the IMTG concentrations within 
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the muscle it may also reduce the triglyceride content of VLDL and chylomicron 
particles, resulting in lower plasma triglyceride concentrations (Mead et al., 2002; 
Durstine and Haskell, 1994).  The hydrolysis of triglyceride-rich lipoproteins can also 
result in the production of more remnants to be converted into HDL.  The increased 
activity of LPL is believed to be one of the major factors for lipid changes seen with an 
increased physical activity level.  However, while being a vital factor, LPL may only 
partially explain how the increased metabolic demands associated with physical activity 
may decrease plasma triglyceride concentrations. 
 Similar to LPL, HL may also serve as a ligand to mediate the interaction of 
lipoproteins with cell surface proteoglycans and/or receptors, facilitating the uptake of 
lipoprotein triglycerides and “recycling” of HDL.  At best, there is weak evidence 
indicating HL activity decreases or remains unchanged with an increase in physical 
activity levels (Magkos et al., 2006; Lambert et al., 1999; Visich et al., 1996; Sady, et al., 
1986).  If physical activity decreased HL activity it could result in a beneficial increase in 
plasma HDL concentrations.  HDL concentrations would increase due to an increase in 
the half-life of HDL2 particles.  However, the interaction of HL and HDL particles is very 
complex and not fully understood by researchers.  Therefore, HL may at least partially 
explain why triglyceride concentrations decrease and HDL concentrations increase with 
physical activity, but it is likely that LPL plays a more vital role. 
 The two lipid transport proteins that have been linked to physical activity and 
lipid transport changes are LCAT and CETP.  LCAT is a plasma glycoprotein responsible 
for most of the esterification of cholesteryl esters in HDL particles.  Data indicates that a 
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single session of exercise may increase LCAT activity (Frey et al., 1991; Olchawa et al., 
2004), but not always (Durstine et al., 1994; Rapp, 2002).  It is possible for LCAT 
activity to increase without an increase in plasma concentration.  If LCAT activity 
increased post acute exercise, it would theoretically lead to a higher plasma concentration 
of HDL-C (Borggreve et al., 2003).  However, more is known about the effects that 
physical activity has on CETP.  CETP catalyzes the net flux of esterified cholesterol from 
cholesterol ester-rich particles (i.e., HDL) to Apo-B containing lipoproteins (i.e., VLDL, 
chylomicrons, and LDL).  CETP activity has been shown to decrease following acute 
exercise (Foger et al., 1994) and physical exercise training (Seip et al., 1993).  While 
some authors dispute the cardioprotective effect of low CETP (Inazu et al., 1990), it is 
believed that decreased CETP activity increases plasma HDL-C and apo A-1 levels, and 
concomitantly reduces HDL-triglyceride content by triglyceride transfer to apo-B 
containing lipoproteins (Leaf, 2003).  With the primary exercise-induced increases in 
HDL-C being attributed to changes in plasma lipase activities, CETP level changes are 
viewed as an additional or secondary factor for the exercise-induced increases in plasma 
HDL-C concentrations (Seip et al., 1993).  While these two transport proteins have the 
potential to affect lipid metabolism, research has not fully defined their primary role or 
association with increased physical activity levels. 
 
Aerobic Exercise Training 
It is well established that aerobic exercise training (e.g., walking, jogging, 
cycling, etc.) is beneficial for reducing both the morbidity and mortality rates associated 
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with CAD.  Numerous excellent review articles have been published in reference to the 
beneficial effects of aerobic exercise training on plasma lipid and lipoprotein 
concentrations (Durstine and Haskell, 1994; Hardman, 1999; Kelley et al., 2004; Kodama 
et al., 2007; Kokkinos and Fernhall, 1999; Leon and Sanchez, 2001; Leaf, 2003; 
Thompson et al., 2001).  However, varied exercise interventions, protocols, and subject 
baseline characteristics have hindered the determination of the most optimal exercise 
dose required to obtain the most beneficial blood plasma concentration changes.  The 
following text will explore some of the relevant findings, in particular those related to the 
study of total cholesterol (TCHL), LDL-C, HDL-C and triglyceride concentration 
changes with aerobic exercise training. 
 
Changes in TCHL and LDL-C Concentrations 
 Regarding endurance exercise training and TCHL and LDL-C changes, few 
studies have shown statistically significant results.  Longitudinal studies report infrequent 
TCHL and LDL-C changes, with the majority (~80%) showing no statistically significant 
reductions after exercise training (Halverstadt et al., 2003; Leon et al., 2002; Kraus et al., 
2002; Nieman et al., 2002; Vislocky et al., 2009).  The small amount of data showing 
TCHL and/or LDL-C reductions (Altena et al., 2006; Halbert et al., 1999; Spate-Douglas 
& Randall, 1999) are largely unreliable due to not accounting for confounding variables 
[e.g., natural fluctuations (no control group), body weight, caloric intake, nutrient 
composition of diets, alcohol intake, and/or smoking)].  When these confounding 
variables are controlled, the reductions in TCHL and/or LDL-C concentrations are 
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generally found to be non-significant (Williams, 1998; Grandjean et al., 1996).  
Therefore, the anti-atherogenic blood profile of aerobically trained individuals is not 
primarily due to low TCHL and LDL-C concentrations.  Instead, exercise training 
appears to produce an anti-atherogenic blood lipid profile by beneficially modifying 
HDL-C and TG concentrations. 
 
Changes in HDL-C and TG Concentrations 
 Research has reported more frequent changes in HDL-C and TG following 
aerobic exercise training.  In fact, more than 50% of the exercise training studies show 
HDL-C improvements, while approximately 33% show TG reductions (Durstine and 
Haskell, 1994; Durstine et al., 2000; Leon et al., 1996).  This increased frequency of 
reported changes indicates that HDL-C and TG are more responsive to exercise training 
compared to TCHL and LDL-C.  While it appears that HDL-C and TG are more 
responsive to exercise training, some studies exist showing small, non-statistically 
significant concentration changes.  Suggested reasons for these disparate findings include 
different training regimens, baseline characteristics, and loss of body weight from pre- to 
post-exercise training (Bassuk and Manson, 2003).  However, when these factors are 
properly controlled, HDL-C and TG concentration changes may be observed following 
an exercise training regimen (Durstine et al., 2000).  
 Compared to any other lipoprotein, physical activity has the most consistent and 
significant effect on HDL-C concentrations (Durstine et al., 2001; Leon et al., 2002).  In 
prospective cohort studies, physically active men and women have significantly higher 
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concentrations of HDL-C compared to their sedentary counterparts (Skoumas et al., 
2003).  Moreover, cross-sectional studies reveal that physically active individuals exhibit 
a 4 to 24 mg/dL higher HDL-C concentration compared with their less active 
counterparts (Durstine et al., 2001; Thompson et al., 2001). 
 Numerous reviews have been conducted on exercise training, supporting HDL-C 
changes.  A review conducted by Leon and Sanchez (2001), analyzed 51 studies (28 
randomized controlled clinical trials that assessed the effects of 12 weeks of aerobic 
exercise training on lipids in adult men and women.  Significant changes in HDL-C 
concentrations were observed in 28 of the 51 studies (47%; P<0.05).  The subset of 
studies also showed that HDL-C concentrations increased significantly (4.6%; P<0.05) 
when dietary factors were held constant.  The data also suggested that neither sex nor age 
were predictors of responsiveness of HDL-C concentration to aerobic exercise training.  
The Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study, a 
20-week intervention study conducted on men and women, resulted in a mean increase in 
HDL-C concentrations of 3.6% (P<0.05) (Leon et al., 2000).  More importantly, the 
observed increase in HDL-C concentrations was similar for males and females, blacks 
and whites, and offspring and parents.  This information supports the fact that exercise 
training alone can elicit HDL-C concentration changes in most individuals independent 
of gender, age, or race. 
 Recent randomized controlled clinical trials testing the effects of at least a 12 
week aerobic exercise training on lipid response, with dietary factors held constant, have 
also shown significant beneficial HDL-C and TG concentration changes.  One such study 
 
32 
 
 
conducted by Kraus et al. (2002) sought to determine the effects of varying levels of 
amounts and intensities of exercise on plasma lipids and lipoproteins.  Overweight, 
sedentary men and women (n = 111) were randomly assigned to participate for 6 months 
in a control group or 8 months in one of three exercise groups: 1) high-amount/high 
intensity exercise (caloric equivalent of jogging 20 miles per week at 65-80% of peak 
oxygen consumption); 2) low-amount/high-intensity exercise (caloric equivalent of 
jobbing 12 miles per week at 65-80% peak oxygen consumption); or 3) low-
amount/moderate-intensity (caloric equivalent of walking 12 miles per week at 40-55% 
of peak oxygen consumption).  Final data showed subjects in the high-amount/high-
intensity group had significantly increased HDL-C concentrations (4 mg/dL) and 
decreased TG concentrations (-35 mg/dL) compared to the low-amount/high-intensity, 
low-amount/moderate-intensity, and control groups.  This indicates that the highest 
amount of exercise produced beneficial changes in HDL-C and TG independent of 
exercise intensity.  Conclusions from this study also indicate that the amount of exercise, 
even in the absence of clinically significant weight loss, can significantly improve HDL-
C and TG concentrations (Table 2).  
 These findings by Kraus et al. (2002) are important, especially when considering 
the dose-response relationship of physical activity and blood lipid profile changes.  
Overall, there appears to be a dose-response relationship that only achieved statistical 
significance at the highest dose.  With regard to intensity of activity, this and other 
studies have not shown a consistent relationship for improvements in plasma HDL-C and 
TG concentrations (Kraus et al., 2002; Crouse et al., 1997).  Therefore, it appears that the  
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Table 2 
The Effects of Aerobic Exercise Training on TG and HDL-C Concentrations 
 
Source Subj 
Study 
Design Int 
Time 
(min) Kcal Timing TG HDL-C 
Altena et al., 18 TM       IPre 83 47 
Med Sci Sport 32 4 weeks 60 30 NR IP -7 3 
Exerc 38(2): UT 5x/week             
367-372, 2006                 
Bounds et al., 14 TM       IPre 183 45 
Int J Sport Nut M 2 weeks 65 NR 350 24HrP -45* 5* 
Ex Metab10(2): 28 3x/week       48HrP -45* 5* 
114-27, 2000 ModT               
Couillard et al., 200 Cycle       IPre 82 31 
Arterio Thromb M 20 weeks 75 50 NR 24HrP -3 0 
Vasc Biol 21: 35 3x/week             
1226-32, 2001 UT               
Crouse et al., 26 Cycle       IPre 207 43 
J Appl Physiol M 24 weeks 50- NR 350 IP -36* 1 
83:2019-28, 47 3x/week 80           
1997 UT               
Grandjean et 
al., J Sports 20 TM/Cycle       IPre 150 40 
Med Phys Fit F 24 weeks 65 30 NR IP -1 6 
36(1):54-9,  45 3x/week             
1996 UT               
Halverstadt et 83 TM/Cycle       IPre 160 46 
al., Metab 52 M/F 24 weeks 70 40 NR IP -18* 3* 
(11): 1505-11, 57 3x/week             
2003 UT               
Kraus et al., 111 TM 40- 12 mi   IPre 197 40 
NEJM 347(19): M/F & Cycle 55 Per NR IP -35* 4* 
1483-92, 2002 52,UT week       
Leon et al., 16 TM     2000 IPre 160 35 
J Cardiopulm M 12 weeks 60 45 per IP -25* 9* 
Rehabil 16(3): 33 5x/week     week       
183-92, 1996 UT               
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Table 2 
The Effects of Aerobic Exercise Training on TG and HDL-C Concentrations (cont.) 
Source Subj 
Study 
Design Int 
Time 
(min) Kcal Timing TG HDL-C 
Leon et al., 675 Cycle     328 IPre 112 41 
Metab 49(4): M/F 20 weeks 75 50 per 24HrP -8 0 
513-20, 2000 36,UT 3x/week     bout 72HrP 0 1 
Leon et al., 675 Cycle     328 IPre 110 41 
Int J Sports  M/F 20 weeks 75 50 per 24HrP -2 4* 
Med 23:1-9, 36 3x/week     bout 72HrP -5 4* 
 2002 UT               
Nieman et al., 91 TM       IPre 145 50 
J Am Coll F 12 weeks 60-80 45 NR 3-wk 3 2 
Nutr 21(4):344 45 5x/week       IP 12 2 
-50, 2002 UT               
Spate-Douglas 13 Walking   6   IPre 32 NR 
et al., Arch F 12 weeks 60 miles NR IP 8* NR 
Phys Med 80: 40 3x/week   per         
691-5, 1999 NR      week         
Vislocky et al., 11 Walk/Jog       IPre 93 60 
J of Nutr M/F 6 weeks 65 60 NR IP 12 6* 
Biochem 20: 24 4x/week             
26-34, 2009 UT               
Williams et 46 Jogging       IPre NR 43 
al, Metabol 43 M 12 weeks 65 30 NR IP NR 5* 
(7):917-24, 44 3x/week             
 1994 UT               
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Table 2 
The Effects of Aerobic Exercise Training on TG and HDL-C Concentrations (cont.) 
Source Subj 
Study 
Design Int 
Time 
(min) Kcal Timing TG HDL-C 
Zmuda et al., 17 Walk/Jog/       IPre 132 38 
Atheroscl 137: M Cycle 60-80 50 NR IP -4 4 
215-21, 1998 39 12 month             
  UT 4x/week             
Subj = subject; n, gender = Male (M) or Female (F); subject average age in years; 
training status = Trained (T) or Untrained (UT). Study Design: Treadmill (TM). Int = 
Intensity in %VO2max. Time (min) = duration of exercise in minutes. Kcal = calories 
expended per session. Timing = timing of blood sample collection; I = Immediate, P = 
Post, Ex = Exercise, Pre = Pre-exercise. TG = triglyceride plasma concentrations. HDL-C 
= high density-lipoprotein-cholesterol plasma concentrations. Not Reported (NR). 
Baseline lipid and lipoproteins are given as mg/dL, then mg/dL change from baseline.  
* Significantly different from baseline, P < 0.05. 
 
 
overall amount of exercise is more important in eliciting blood lipid profile changes 
compared to exercise intensity. 
 While mean HDL-C concentrations generally improve consistently across entire 
treatment groups in interventional studies, some have reported significant individual 
variability.  One study suggests that baseline HDL cholesterol concentrations may affect 
responsiveness to physical activity (Kokkinos and Fernhall, 1999; Kelley et al., 2005).  
Data regarding this variation is inconsistent when considering whether greater benefits 
occur with low- (Leon et al., 2000; Leon et al., 2002) versus normal- to high-baseline 
HDL-C cholesterol concentrations (Zmuda et al., 1998; Couillard et al., 2001; Thompson 
et al., 2001).  It may be reasonable to assume that less physically fit individuals, who tend 
to display lower baseline HDL-C concentrations, may be more responsive to physical 
activity.  However, information obtained by Williams and colleagues (1994) found that 
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exercise training increased HDL-C to a lesser extent in men with low versus normal 
baseline HDL-C cholesterol.  Similar data has been collected for female subjects 
(Halbert, 1999), suggest little if any between gender difference in the HDL-C response to 
physical activity.  Moreover, a study conducted by Couillard et al. (2001) found that 
endurance exercise can improve the lipid profile of obese men with initially low HDL-C 
and elevated TG concentrations.  However, the blood lipid profiles of similarly obese 
men with initially low HDL-C as an isolated trait (i.e., normal TG concentrations) were 
less responsive to endurance exercise training.  Therefore, the beneficial HDL-C 
cholesterol response elicited by physical activity may not be similar independent of 
baseline concentrations. 
 Triglycerides are increasingly being recognized as an independent cardiovascular 
risk factor (Cullen, 2000) and may be modified by regular exercise training.  While 
exercise training appears to modify TG levels, significant reductions are reported less 
frequently than increases in HDL-C.  Specifically, reductions in TG concentrations have 
been found in approximately 33% of the related literature (Leon et al., 2001; Durstine et 
al., 2000).  Studies reporting significant TG reductions have ranged from 5 to 38 mg/dL 
reductions, observed 18 to 72 hours post-exercise.  While not reported as frequently, TG 
concentration changes occur in a similar post-exercise timeline as HDL-C changes 
(Bounds et al., 2000; Crouse et al., 1997; Cullinane et al., 1982; Foger et al., 1994) (Table 
2). 
 Although some studies fail to show reduced TG following exercise training, most 
of these studies involve subjects with low baseline TG concentrations.  Furthermore, a 
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relationship exists between pre-exercise TG concentration and the magnitude of the post-
exercise change.  Therefore, subjects with elevated pre-exercise TG values typically 
show the greatest post-exercise changes compared to subjects with lower initial TG 
values (Crouse et al., 1995).  Also, research has shown that a reduction in body weight 
(i.e. adiposity) is not a prerequisite for exercise to produce significant post-exercise 
changes in TG concentrations (Durstine et al., 2001).   
 In summary, it is evident that aerobic exercise training can often be effective in 
raising HDL-C and lowering TG concentrations.  These changes generally occur during 
similar post-exercise time frames (i.e., 24-72 hours) due to the role of HDL molecules in 
the delivery of TG to other lipoproteins (i.e., VLDL and LDL) and the action of other 
metabolic factors (i.e., LCAT, CETP, and LPL).  The beneficial HDL-C and TG changes 
elicited by exercise training appear to occur independent of age, sex, or race.  More 
importantly, the beneficial post-exercise blood lipid changes can be elicited due to a 
metabolic response to exercise rather than a reduction in body weight (i.e., adiposity).  
While research has proposed a general recommendation for exercise training (e.g., 12-
weeks of at least 1200 kcal expenditure per week), the exact dose-response relationship 
has not been established.  Determining this relationship has proven to be difficult due to 
the wide variance in exercise protocols (i.e., dose per session, time between each exercise 
session).  In order to define the exercise training dose-response relationship it is 
necessary to understand the effects of a single session of exercise. 
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Single-Sessions of Exercise 
 Exercise training involves the accumulation effects from a single exercise 
sessions.  Fuel substrates required for the performance of aerobic exercise primarily 
comes from the mobilization and oxidation of carbohydrate and lipid stores.  Therefore, it 
can be reasonably expected that a single session of exercise can modify lipid and 
lipoprotein metabolism.  In fact, it is possible that the anti-atherogenic lipid profile of an 
exercise trained individual is, at least in part, a consequence of a delayed (hours) response 
to the last session of exercise independent of the training response (Thompson et al., 
2001). 
 While many exercise-induced metabolic changes (i.e., decrease in insulin 
resistance, reductions in blood pressure, increased coronary blood flow, etc.) contribute 
to the reduction in CAD risk, plasma lipid profile changes appear to be among the most 
modifiable (Haskell, 2001).  Although not defined, previous research suggests that some 
of the blood lipid effects elicited by exercise training may occur as an acute response to 
single sessions of exercise, some only as a training response, and some as the result of an 
interaction between the two.  Defining these interactions has proven to be difficult for 
researchers, and is the primary reason there is not a defined dose of exercise required to 
optimally modify an individuals’ blood lipid profile.  However, researchers agree that 
defining a dose-response relationship should begin by assessing the effects of single 
sessions of exercise followed by testing the proper accumulation of these individual 
sessions into an optimal exercise training program (Haskell, 1994). 
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Total work performed during a single session of exercise is generally reported as 
either total time or calories expended, with exercise intensity typically defined as 
percentage of maximal oxygen consumption.  Physical activity recommendations utilize 
total time, while blood lipid specific research has primarily reported caloric expenditure.  
Therefore, the majority of the research presented in this section reports caloric 
expenditure.  However, it is the aim of this study to utilize the IOM’s physical activity 
recommendation of 90 minutes of moderate intensity exercise to assess the interaction 
between acute and short-term training responses on blood lipid profile changes. 
 Past intervention protocols analyzing the blood lipid and lipoprotein 
response to a single session of exercise vary widely.  This is not surprising when 
considering various confounding factors (i.e., age, gender, training status, body 
composition, baseline lipid concentrations, and plasma volume expansion).  Along with 
these subject-based factors, previous research has varied in mode, duration, intensity, and 
volume (energy expenditure) of the exercise stimulus.  All of these factors have the 
potential to affect lipid and lipoprotein concentrations and should be considered when 
interpreting published research related to the lipid response to a single session of 
exercise.  Also, since exercise-induced alterations in plasma volume can affect lipid and 
lipoprotein concentrations, all of the studies discussed report their concentrations after 
correction for plasma volume change. 
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Changes in TCHL and LDL-C Concentrations 
 Studies examining the TCHL and LDL-C response to a single session of exercise 
generally show no changes, however some variability is noted.  Many well-controlled 
studies have shown that a reduction in TCHL may occur after a single session of exercise.  
However, these small TCHL reductions are very short-lived (<24 hours) and rarely reach 
statistical significance (Bounds et al., 2000; Crouse et al., 1997; Crouse et al., 1995; 
Grandjean et al., 2000; Hughes et al., 1990; Kantor et al., 1987).  Moreover, exercise 
requiring a higher caloric output (i.e., >1,000 kcal) has been weakly associated with a 
longer lasting post-exercise TCHL reduction (i.e., up to 120 hours post-exercise) (Foger 
et al., 1994).  While these data weakly support a post-exercise TCHL reduction, there are 
an equal number of studies showing no post-exercise changes (Davis et al., 1992; 
Ferguson et al., 1998; Imamura et al., 2000; Sady et al., 1996; Visich et al., 1996).  
Moreover, increases in plasma TCHL concentrations have been observed 24 to 48 hours 
after exercise in untrained men with normal and elevated blood cholesterol (Crouse et al., 
1997; Crouse et al., 1995; Kantor et al., 1987).  In summary, it appears that even a 
prolonged (i.e., marathon) session of exercise may not produce consistent and/or 
significant reductions in post-exercise TCHL concentrations. 
 Similar to the findings noted for TCHL, LDL-C exhibits a highly variable 
response to a single session of exercise.  This is not surprising when considering that the 
primary lipoproteins responsible for carrying the bulk of circulating cholesterol are LDL 
molecules.  Reductions in LDL-C that range from zero to 38% have been reported in 
trained men immediately and up to 72 hours after completing marathon type exercise 
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(>800 kcal energy expenditure) (Bounds et al., 2000; Ferguson et al., 1998; Foger et al., 
1994; Sady et al., 1986; Visich et al., 1996).  However, small increases (5%) and 
decreases (8%) in post-exercise LDL-C concentrations have been observed in 
hypercholesterolemic men post-exercise (energy expenditure ranging from 350 to 500 
kcal) (Crouse et al., 1997; Crouse et al., 1995; Grandjean et al., 2000; Hughes et al., 
1990).  The conflicting LDL-C changes after exercise are likely due to the variation in 
energy expenditure and the training status of the hypercholesterolemic men.  These data 
indicate the possibility that hypercholesterolemic men may react to exercise differently 
than normocholesterolemic men, but this hypothesis requires more research. 
 Data on LDL-C changes in women is sparse, but reductions have been reported 24 
hours after performing marathon type exercise (Pronk et al., 1995; Goodyear et al., 1990).  
However, data collected utilizing smaller amounts of caloric expenditure (i.e., 300 to 500 
kcal) have shown no post-exercise LDL-C concentration changes in young vs. old or 
normal vs. hypercholesterolemic women (Crouse et al., 1999; Imamura et al., 2000).  
These trends are similar to those found in male subjects.  Overall, it appears that the 
stimulus of an acute session of exercise (e.g., 350-500 kcal) is not enough to significantly 
reduce TCHL and/or LDL-C concentrations in either male or female subjects (Thompson 
et al., 2001). 
 
Changes in HDL-C and TG Concentrations 
 Since HDL-C is inversely related to the risk of developing CAD, this lipoprotein 
has received a significant amount of research attention.  Plasma TG concentrations have 
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also been extensively studied, with recent prospective cohort studies establishing it as a 
significant and independent risk factor for CAD (Assmann et al., 1998; Hokanson and 
Austin, 1996).  The general consensus of research findings indicates that single sessions 
of exercise are effective stimuli for temporarily elevating HDL-C and reducing TG 
concentrations.  These temporary effects observed after a single session of exercise are 
believed to, at least partially, account for the anti-atherogenic lipid profile of an 
aerobically trained individual.  Concentration increases in HDL-C range from 3 to 14 
mg/dL and appear to peak 24 to 48 hours post-exercise before returning to pre-exercise 
concentrations by 72 hours (Thompson et al., 2001).  In a similar time frame, reductions 
in TG range from 5 to 26 mg/dL and appear to peak 18 to 24 hours post-exercise and may 
persist for up to 72 hours (Thompson et al., 2001).  Past research has utilized exercise 
protocols with intensities ranging from 50 to 90% VO2max and durations from 12 to 244 
minutes (i.e., 350 to 1500 kcal energy expenditure), respectively (Angelopoulos et al., 
1993; Bounds et al., 2000; Crouse et al., 1997; Crouse et al., 1995; Davis et al., 1992; 
Ferguson et al., 1998; Foger et al., 1994; Frey et al., 1993; Goodyear et al., 1990; Gordon 
et al., 1998; Grandjean et al., 2001; Hughes et al., 1990; Imamura et al., 2000; Kantor et 
al., 1987; Kantor et al., 1984; Lee et al., 1991; Lennon et al., 1983; Park and Ransone, 
2003; Swank et al., 1987; Tsetsonis & Hardman, 1995; Visich et al., 1996).  Therefore, 
numerous articles and abstracts have examined the acute effect of exercise on lipids and 
lipoproteins, as shown in Table 3.  However, the wide ranges of exercise intensities and 
durations have made it difficult to define an optimal exercise dose required to produce a 
metabolic response. 
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Table 3 
The Effects of Single Sessions of Exercise on TG and HDL-C Concentrations 
 
Source Subj Mode 
Intensity 
(% max) 
Time 
(min) Kcal Timing TG HDL-C 
Angelopoulos &  7M TM 65 30 NR IPre 93 42 
Robertson, J Sp 22         24HrP -11 0 
Med Phys Fitness UT         48HrP -1 0 
33:264-267, 1993                 
Angelopoulos & 7M TM 65 30 NR IPpre 123 39 
Robertson, Int 22         24HrP 48 1* 
J Sp Med UT         48HrP 5 0 
14:196-201, 1993                 
Bounds et al., 14M TM 70 ~108 1000 24HrPre 113 48 
Exerc. Metab 10: 28         24HrP -16 5* 
114-127, 2000 T         48HrP -25* 4* 
Crouse et al., 15M TM 60 NR 500 Low 
Med Sci Sports 44   -70     24HrPre 190 35 
Exerc 33(5) UT         24HrP -25* 3* 
(S1): May, 2001           48HrP -25* 3* 
            Moderate 
            24HrPre 103 51 
            24HrP -13* 5* 
            48HrP -13* 5* 
Crouse, et al. 26M Cycle 50 NR 350 IPre 207 43 
JAP 83:2019- 47         24HrP -44* 5* 
2028, 1997 UT         48HrP -34* 6* 
Crouse et al., 39M Cycle 50 & NR 350 IPre 177 45 
JAP 79:279- 46   80     24HrP -33* 4* 
286, 1995 UT         48HrP -26* 5* 
Davis et al.,  10M TM 50 90 950 IPre 79 56 
JAP 72(3): 914- 28         24HrP -10 0 
919, 1992 T         48HrP -7 0 
            72HrP -2 3 
Ferguson et al., 11M TM 70 60 800 IPre 110 42 
 JAP 85(3):1169- 32     to to 24HrP -40* 12* 
1174, 1998 T     112 1500 48HrP -19* 10* 
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Table 3 
The Effects of Single Sessions of Exercise on TG and HDL-C Concentrations (cont.) 
Source Subj Mode 
Intensity 
(% max) 
Time 
(min) Kcal Timing TG HDL-C 
Frey et al.,  13M Run 78 130 NR IPre 97 56 
Euro J Appl Phys 31         20HrP -30* 0 
66:521-25, 1993 T               
Gordon et al., 12F TM 75 NR 800 IPre 97 60 
Br J Sports Med 27         24HrP -21 0 
 32: 63-67, 1998 T         48HrP -23 5* 
Grandjean et al., 25M TM 70 NR 500 Normocholesterolemic 
JAP 89:472-480, 45         IPre 140 43 
2000 UT         24HrP -16* 4* 
            48HrP -16* 6* 
            Hypercholesterolemic 
            IPre 155 41 
            24HrP -15* 2* 
            48HrP -19* 5* 
Hughes et al., 24M TM 20% 15 NR IPre 108 50 
J Sports Med Phys 25   below 30   24HrP -20 3* 
Fitness 30:37-44, T   LT 45   48HrP 15 -1 
1990                 
Imamura, et al. 7F Cycle 60 30 170 Ipre 62 54 
ClinExPathPharm, 22     60 321 24HrP -6 0 
2000 UT               
Kantor et al., 21M Cycle 80 60 NR 24HrPre 97 39 
Metabol 36(2): 31         24HrP 8 3* 
188-192, 1987 UT         48HrP 13 3* 
            72HrP 9 3* 
Kantor et al., 10M Run 85 188 NR 24HrPre 95 65 
Metabol 33(5): 29         18HrP -34* 10* 
454-457, 1984 T         42HrP -26* 13* 
Park, et al. 18M TM 70% NR 350 IPre 266 46 
Int.J.SpMed 24: 25   LT,     24HrP -27* 4* 
2003 UT   LT           
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Table 3 
The Effects of Single Sessions of Exercise on TG and HDL-C Concentrations (cont.) 
Source Subj Mode 
Intensity 
(% max) 
Time 
(min) Kcal Timing TG HDL-C 
Swank et al., 9M TM 70 40 NR IPre 91 62 
Atherscl 63:187- 25         24HrP -7 1 
192, 1987 T         48HrP -6 0 
            96HrP -3 2 
Tsetsonis & 5M/7F TM 30 & 90 NR IPre 74 50 
Hardman, Eur 28   60     24HrP -14 1 
J Appl Physiol UT               
70:329-36, 1995                 
Visich et al., 12M TM 74 28 400 24HrPre 67 40 
EJP 72:242-248, 26     41 600 24HrP -13* 6* 
1996 T     55 800       
Wooten & 11F TM 65 NR 500 IPre 103 51 
Biggerstaff, Eur J 24         24HrP -20 -1 
Appl Physiol UT         48HrP -26* -5* 
104: 19-27, 2008                 
Zhang et al., 16M TM 60 60 ~500 IPre 198 34 
Am J Endocrinol 29         24HrP -18* 0 
Metab 283:E267- UT               
E274, 2002                 
Subjects: n = subject number; gender = Male (M) or Female (F); age in years; training 
status = Trained (T) or Untrained (UT). Mode: Treadmill (TM). Duration: minutes (min).  
Not Reported (NR). Timing: I = Immediate, P = Post, Ex = Exercise, Hr = Hour(s). TG = 
Triglycerides. HDL-C = High Density Lipoprotein-Cholesterol. Baseline lipids and 
lipoprotein-lipids are given as mg/dL, then mg/dL change from baseline.  
* Significantly different from baseline, P < 0.05. 
 
 
Many experimental studies have reported simultaneous increases in HDL-C and 
reductions in TG concentrations.  Crouse et al., (1995) utilized 39 hypercholesterolemic, 
untrained men (~45 years of age; BMI=28 kg/m2) to compare the effects of a single cycle 
ergometer exercise session at moderate (i.e., 50% VO2max) versus high (80% VO2max) 
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intensity exercise.  Subjects were required to expend 350 kcals, which took 60 minutes at 
the moderate intensity and 35 minutes at the high intensity, respectively.  Both exercise 
intensities showed similar statistically significant elevations (+4 mg/dL) in HDL-C and 
reductions in TG (-25 mg/dL) concentrations 24 and 48 hours post-exercise.  Grandjean 
et al., (2000) reported similar findings when comparing hypercholesterolemic (n= 13) to 
normocholesterolemic (n=12) men (~45 years of age; BMI=27.8 kg/m2).  Subjects 
performed a treadmill session, requiring 500 kcal, at 70% VO2max.  While total exercise 
time was not reported, it can be calculated that exercise time was 45-60 minutes.  
Subjects demonstrated a concomitant 14% increase (+11 mg/dL) in HDL-C 
concentrations and a 10% reduction (-11.1 mg/dL) in TG concentrations 24 and 48 hours 
post-exercise.  Crouse and colleagues (2001) recruited sedentary middle-aged men (~44 
years of age) with initially moderate (e.g., ~50 mg/dL) or low (e.g., 35 mg/dL) HDL-C 
concentrations.  After expending 500 kcal during a treadmill run at 60 to 70% VO2max, all 
subjects demonstrated an increase in HDL-C (+3.2 mg/dL) and reduction in TG 
concentrations (-24.7 mg/dL) 24 and 48 hours post-exercise. 
Taken together, the evidence indicates that a single session of exercise can 
stimulate concomitant elevations in HDL-C and reductions in TG concentrations.  Most 
research indicates that initial blood lipid profile will not affect the extent of post-exercise 
blood lipid profile changes.  However, individuals with initially low HDL-C levels as an 
isolated trait (i.e., without elevated TG concentrations) may be less responsive to exercise 
induced blood lipid profile changes (Couillard et al., 2001).  A single session of exercise 
lasting between 35 and 60 minutes was reported to be sufficient for stimulating post-
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exercise lipid metabolism changes, regardless of exercise intensity.  Since these studies 
utilized middle-aged caucasian males, the results cannot be generalized to other 
populations.  However, there are similarities between these findings and the results of 
single session exercise in younger, untrained individuals. 
Research on young untrained individuals has produced mixed results in terms of 
the effects of a single session of exercise on post-exercise HDL-C and TG concentrations.  
Since most untrained individuals are not able to perform long duration exercise, most 
studies involve a moderate amount of exercise at a moderate intensity.  With the 
exception of a few studies (Angelopoulos and Robertson, 1993; Imamura et al., 2000, 
Magkos et al., 2006, Wooten et al., 2008), numerous studies indicate that a single session 
of exercise can produce beneficial HDL-C and/or TG concentration changes in young, 
untrained individuals.  A study conducted by Kantor and colleagues (1987) assessed the 
lipid profiles of young (25-39 years of age) men before and after a cycle ergometer 
session at 80% VO2max.  Untrained subjects (n=10) cycled for one hour while trained 
(n=11) subjects cycled for two hours, implemented to represent a hard daily workout.  
Although exercise time was not matched, both trained and untrained subjects experienced 
similar statistically significant elevations in HDL-C concentrations (~ 5 mg/dL) from pre 
to 24, 48, and 72 hours post-exercise.  Similar changes have been reported by Alhassan et 
al. (2001; abstract) for HDL-C concentrations following a treadmill bout at 60 to 
70%VO2max, requiring 350 kcal.  Utilizing 14 sedentary, African-American females (~32 
years of age), HDL-C was significantly elevated immediately through 48 hours post-
exercise.  While HDL-C concentrations were beneficially altered, no significant TG 
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concentration changes were observed.  However, other studies assessing young, untrained 
individuals have shown TG concentrations to be more responsive than HDL-C levels. 
A study conducted by Lee and colleagues (1991) recruited 24-45 year old women 
(n=12) who were untrained and mildly obese.  Data results showed significant reductions 
(-5mg/dL) in TG concentrations ~24 hours after performing a 45 minute treadmill walk at 
60% VO2max.  Tsetsonis & Hardman (1995) found similar results in young (~28 years 
old) untrained subjects (five men; seven women).  In random order, subjects performed 
treadmill exercise for 90 minutes at 30%VO2max and 60%VO2max.  Significant TG 
concentration reductions (-3 mg/dL) were observed in all subjects, independent of 
intensity, 24 hours post-exercise.  Zhang and colleagues (2002) pre-screened TG 
concentrations for 16 sedentary male subjects (~38 years old), classifying 10 as normal 
and six as hypertriglyceridemic.  All subjects performed an hour treadmill session at 60% 
VO2max, with hypertriglyceridemic subjects presenting a decreased TG concentration 
(~37 mg/dL) 24 hours post-exercise.  While both the normal and hypertriglyceridemic 
subjects experienced similar LPL increases, the subjects with normal pre-exercise TG 
concentrations showed no post-exercise lipid changes (See Table 3). 
In summary, research conducted on young, untrained individuals is somewhat 
discrepant.  Some studies report only increased post-exercise HDL-C concentrations, 
while others report only reduced post-exercise TG concentrations.  In support of all 
previously reported single session articles, it appears that exercise intensity alone does 
not affect post-exercise lipid metabolism.  From these studies it appears that a young, 
untrained individual needs to perform a minimum of 45 to 60 minutes (e.g., >350 kcal 
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energy expenditure) of exercise to elicit post-exercise HDL-C and/or TG concentration 
changes, independent of gender or race.  Although, there is no guarantee that both HDL-
C and TG concentrations will concomitantly improve, these plasma markers still appear 
to be independently modifiable in young, untrained individuals. 
Apart from a few studies (Davis et al., 1992; Hughes et al., 1990; Imamura et al., 
2000; Lennon et al., 1983; Swank et al., 1987), exercise of longer duration (i.e., higher 
caloric expenditure) generally elicits beneficial post-exercise HDL-C and TG 
concentration changes (See Table 3).  However, similar to the data presented on young, 
untrained individuals, there is no guarantee that exercise will significantly modify both 
HDL-C and TG concentrations post-exercise.  For example, Hughes et al. (1990) required 
24 moderately trained normolipidemic males (19-31 years of age) to perform a 30 and 45 
minute treadmill run, in a random crossover design, at 20% below lactate threshold.  
While both exercise durations produced a decreasing trend in post-exercise TG, 
concentrations did not reach statistical significance.  However, data from the 45 minute 
session showed significantly higher HDL-C concentrations at 24 hours post-exercise 
compared to data from the 30 minute session.  Results also showed these HDL-C 
increases were returning toward baseline levels by 48 hours post-exercise. 
Utilizing similar subjects, Gordon and colleagues (1998) required young (18-35 
years of age) moderately trained females to perform a treadmill run at 75% VO2max for 
approximately 72 minutes (800 kcal).  TG concentrations showed a non-significant trend 
toward a decrease, while HDL-C concentrations increased 24 hours post-exercise, 
becoming significant (5 mg/dL) at 48 hours post-exercise.  Additionally, Bounds et al., 
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(2000) recruited 14 moderately trained men (~28 years of age) and had them exercise at 
70% VO2max for approximately 108 minutes (~1,000 kcal).  Results showed a significant 
(e.g., 11 mg/dL) increase in HDL-C 24 hours after exercise and remained significantly 
elevated (e.g., 8 mg/dL) until 48 hours after exercise.  Moreover, TG concentrations 
showed a significant (e.g., 16 mg/dL) decrease 24 hours post-exercise and remained 
significant (e.g., 25 mg/dL) through 48 hours post-exercise.  These studies indicate that 
young, moderately trained individuals may be able to significantly increase HDL-C 
concentrations, and potentially reduce TG concentrations, by performing an exercise bout 
lasting between 30 and 72 minutes. 
To test this exercise duration range, Ferguson and coworkers (1998) assessed 
HDL-C and TG concentrations following 70% VO2max treadmill runs in trained males.  
Eleven trained men (21-44 years of age), in a random crossover design, performed 
treadmill bouts requiring 800, 1,100, 1,300, and 1,500 kcal.  Final data indicates that an 
energy expenditure of 1,500 kcal was the most effective in significantly decreasing post-
exercise TG concentrations (e.g., 31 mg/dL decrease 24 hours post-exercise and 13 
mg/dL decrease 48 hours post-exercise).  Moreover, 1,500 kcal expenditure produced 
statistically significant HDL-C concentration changes immediately post-exercise (e.g., 6 
mg/dL increase), 24 hours post-exercise (e.g., 9 mg/dL increase), and 48 hours post-
exercise (e.g., 7 mg/dL increase).  Similar to the 1,500 kcal exercise bout the 1,100 and 
1,300 kcal exercise bouts elicited statistically significant HDL-C and TG concentrations 
24 hours post-exercise.  However, these significant changes returned to non-significant 
levels by 48 hours post-exercise.  Therefore, this study indicates that a 1,500 kcal 
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exercise bout is required to elicit statistically significant HDL-C and TG concentration 
changes both at 24 and 48 hours post-exercise.   
An earlier study conducted by Kantor et al., (1984) supports the findings of 
Ferguson.  Kantor assessed the effects of a 42 kilometer race (~188 minutes of exercise) 
on ten trained male runners (~30 years old).  This prolonged session of exercise elicited a 
significant increase (e.g., 10 mg/dL) in HDL-C 18 hours after exercise, remaining 
elevated 42 hours post-exercise (e.g., 13 mg/dL).  Moreover, TG concentrations were 
significantly decreased (e.g., 34 mg/dL) 18 hours post-exercise, remaining significantly 
decreased through 42 hours post-exercise (e.g., 26 mg/dL).  A more recent prolonged 
exercise study conducted by Frey et al., (1993) also supports the findings of Ferguson.  
Frey had 13 endurance trained males (~31 years of age) perform a 30 kilometer run (~130 
minutes) at ~80% VO2max.  Results showed a statistically significant decrease (e.g., 30 
mg/dL) in TG concentrations 20 hours post-exercise.  However, this study did not 
examine blood samples beyond 20 hours post-exercise, limiting the results of post-
exercise lipid changes.  
Taken together, these findings suggest that acute bouts of aerobic exercise can 
increase HDL-C concentrations in young, trained males and females.  The increase in 
HDL-C and decrease in TG concentrations appear to peak approximately 24 to 48 hours 
post-exercise then begin to return to baseline levels thereafter.  This time line for HDL-C 
and TG change, as well as the magnitude of change (e.g., percent increase from pre to 
post-exercise) appears to be similar for both genders.  Moreover, these studies utilized 
subjects with normal to high baseline HDL-C concentrations (~40-56 mg/dL) who still 
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exhibited the ability to temporarily modify HDL-C levels via a single session of exercise.  
This is vital in that more sedentary individuals (i.e., untrained) may not have to perform 
as much exercise to elicit blood lipid profile changes compared to more trained 
individuals.  Finally, these studies suggest that HDL-C concentration changes are 
primarily related to exercise duration rather than exercise intensity (Ferguson et al., 1998; 
Hughes et al., 1990). 
 
Acute Augmented Exercise Response 
 The majority of the literature presented in this review indicates that both a single 
session and exercise training can beneficially alter post-exercise plasma lipids and 
lipoproteins.  Significant increases in HDL-C concentrations are reported after a single 
session (i.e., moderate intensity session lasting from 30 to 188 minutes) of exercise, 
ranging from 2 to 13 mg/dL (5-20%).  These beneficial changes in HDL-C were typically 
observed from 1.5 to 48 hours post-exercise.  Similarly, significant reductions in TG 
concentrations range from 5 to 37 mg/dL (4-36%), and are seen within a similar post-
exercise timeframe as HDL-C changes.  Exercise training studies [typically based upon a 
physical activity recommendation (i.e., >20 weeks, >3 sessions per week, moderate 
intensity, >30 minutes per session)] show significant increases in HDL-C ranging from 2 
to 8 mg/dL (4-22%), reaching peak concentrations by 24-48 hours post-training (Table 
2).  Likewise, significant reductions in TG concentrations range from 5 to 38 mg/dL (4-
37%), and are seen within a similar post-study timeframe as compared to HDL-C.  For 
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acute exercise and exercise training, HDL-C and TG concentrations returned to pre-
study/exercise concentrations within 72 hours post-exercise. 
 Therefore, both acute and exercise training have been shown to increase HDL-C 
and decrease TG concentrations to a similar magnitude and post-exercise time frames.  
However, there are internal differences between the two methods of assessing post-
exercise lipid and lipoprotein concentrations, which have not been answered.  Firstly, the 
effect of exercise frequency on post-exercise blood lipid changes has not been directly 
assessed.  Most exercise training studies implement multiple weeks of training during 
which subjects are required to perform a set number of weekly exercise sessions.  The 
specific frequency of these weekly exercise sessions is generally not defined (i.e., every 
day, every other day, etc.).  This set up does not allow the researcher the ability to 
conclude on any short-term (i.e., one to three sessions) exercise frequency based 
hypotheses.  Secondly, most studies assess pre- and post-exercise training (i.e, 
immediate, 24, 48, 72, and/or 96 hours after the last individual exercise session of the 
training protocol).  With approximately 12 weeks between these two blood samples, any 
mid-study (i.e., daily or weekly) blood concentration fluctuations are missed.  By not 
measuring multiple time-points throughout an exercise training study, little data exists 
assessing the “acute augmented response”. 
 The acute augmented response suggests that accumulating repeated sessions of 
exercise produces an additive effect beyond that of a single session of exercise 
(Grandjean et al., 2001).  It is hypothesized that accumulated sessions of exercise will 
produce an additive effect (i.e., greater reduction in CAD risk) on an individual’s blood 
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lipid profile.  This additive effect occurs because subsequent exercise sessions are 
performed while the blood lipid profile is still favorably altered due to the previous 
exercise session (Figure 3).  Therefore, this augmented response may occur briefly after 1 
to 2 exercise sessions, then reach a natural limit (i.e., plateau in beneficial effects) 
(Durstine et al., 1994; Thompson et al., 2001).  Chronic exercise training shows 
beneficial results as well as acute, however, it is not know if these beneficial results are 
due to the accumulation of exercise or the effects of one exercise stimulus. 
  Regarding single session exercise and the acute augmented response, few data 
are presently available.  Angelopoulos et al. (1993) studied the lipid response of nine 
untrained men (~22 years of age) after 30 minute treadmill bouts at 65% VO2max.  Nine 
young (e.g., 22 years old) male subjects performed three exercise patterns (each pattern 
separated by a seven day period): (1) single session, (2) two sessions (separated by 48 
hours), and (3) three sessions (each separated by 48 hours).  Blood samples were drawn 
at five minutes, 24 and 48 hours after the last exercise session within each experimental 
pattern.  Final results showed that HDL-C was significantly increased 24 hours post-
exercise for all exercise patterns, then quickly returned to pre-exercise concentrations by 
48 hours post-exercise.  Exercise pattern(1) elicited a 1 mg/dL increase; pattern (2) 
elicited a 2 mg/dL increase, while pattern (3) elicited a 4 mg/dL increase.  This pattern of 
post-exercise HDL-C change supports the position that accumulating single sessions of 
exercise in a set frequency may produce an additive effect.  Moreover, an additive effect 
which produces greater health benefits beyond those observed after a single session of  
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Figure 3 
Acute Augmented Exercise Response 
             
Magnitude 
of Health 
Benefits
Baseline 
Health
Exercise 
Bout    
#1
Exercise 
Bout    
#2
0 24 48 72 96 120(Hours)
#1 #2
#1 + #2?
144
#3
#1 + #2 +#3?
Exercise 
Bout    
#3
168
 
Acute Augmented Exercise Response.  Performing a bout of exercise (exercise bout #1, 
above) generally produces a known magnitude of health benefits, as seen with the solid 
black lines, which return to baseline health concentrations after a set amount of time (i.e., 
48-72 hours post-exercise).  Currently, it is assumed that this acute response to a single 
bout of exercise will be observed with each additional exercise bout (i.e., exercise bout 
#2 and #3).  However, it is hypothesized that accumulating repeated bouts of exercise 
will produce an additive effect beyond that of a single bout of exercise.  This 
phenomenon may occur because accumulated sessions of exercise will produce an 
additive effect on the magnitude of health benefits (dotted lines) because subsequent 
exercise bouts are performed while health benefits are still favorably altered from the 
previous exercise bout. 
  
 
56 
 
 
exercise.  It is important to note that blood samples were not obtained before the second 
[i.e., pattern (2)] exercise session or before the second and third [i.e., pattern (3)].  
Interestingly, the results did not show HDL-C concentrations staying significantly 
elevated beyond 24 hours post-exercise for any exercise pattern.  This study did not show 
any statistically significant TG changes, although a substantial decline (~28 mg/dL) in 
TG concentrations was observed 24 hours post-exercise in pattern three. Therefore, it is 
possible that some of the benefits of accumulating two and three exercise sessions were 
not fully measured. 
 A study attempting to answer the acute augmented response question was recently 
conducted by Biggerstaff et al. (2005-abstract).  This study utilized a similar exercise 
protocol as compared to Angelopoulos et al. (1993).  Eleven young (e.g., 25 years old) 
female subjects performed three exercise sessions, each session separated by 48 hours.  
Treadmill exercise was performed at 65% VO2max for a duration requiring 500kcal (~45 
minutes).  Blood samples were obtained based upon the first exercise session as follows: 
immediately pre, 24 hours post, 48 hours post (coordinating with exercise session #2 
conducted 48 hours after the first exercise session), 96 hours post (coordinating with 
exercise session #3 conducted 96 hours after the first exercise session), and 144 hours 
post (acting as a 48 hour post-exercise session #3).  Therefore, unlike Angelopoulos et al. 
(1993), this study did attempt to assess blood lipid and lipoprotein concentration changes 
throughout an accumulated exercise protocol.  It is also important to note that this study 
did have all subjects perform a resting protocol in which subjects followed the same 
blood sampling protocol, but simply relaxed in a chair for ~45 minutes instead of 
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exercising.  A significant reduction in TG concentrations (i.e., 20 mg/dL) was observed 
48 hours after the third exercise session.  HDL-C concentrations were trending upward at 
the 96-hour blood sampling, but were not significant, while appearing to begin to return 
to pre-exercise concentrations by 48 hours post-exercise session #3. 
 Grandjean and colleagues (2001) conducted a study to determine the serum lipid 
and lipoprotein responses to repeated sessions of exercise on successive days (abstract).  
Fifteen hyperlipidemic men (~50 years old) expended 350 kcals via treadmill 
walking/jogging at 70% VO2max for four consecutive days (24 hours between each 
session).  Blood samples were obtained prior to all four exercise sessions, then 24 and 72 
hours after the fourth exercise session.  Final results showed one session of exercise 
significantly raised HDL-C concentrations by 1.5 mg/dL and significantly lowered TG 
concentrations by 40 mg/dL.  Moreover, as successive exercise sessions were performed 
both HDL-C and TG levels continued to improve in an additive manner.  These 
concentration improvements persisted for three days after the last exercise session.  This 
indicates that four days of successive exercise produces an additive effect that 
beneficially alters HDL-C and TG concentrations, while also increasing the amount of 
time in which these benefits persist (i.e., post-exercise). 
 A recent study conducted by Mestek et al. (2006) partially assessed the acute 
augmented response to exercise.  This study compared the effects of one 500 kcal 
exercise session to three 167 kcal exercise sessions, both completed within one day.  Nine 
moderately trained male subjects (20-30 years of age) completed one-500 kcal exercise 
session and three-167 kcal exercise sessions, separated by at least one week.  Both 
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exercise protocols were performed at 70% VO2max on a treadmill.  For the three-167 kcal 
exercise protocol, a minimum four hours of rest was required between each session.   
Therefore, subjects completed all three exercise sessions (i.e., morning, mid-day, and 
evening) within one day.  The most significant finding was the accumulated (i.e., three 
sessions of 167 kcals each) was more effective in terms of raising HDL-C than the single 
500 kcal session of exercise.  Compared to pre-exercise HDL-C concentrations, the three-
167 kcal exercise protocol elicited significant increases at 24 (5 mg/dL) and 48 hours 
post-exercise (7 mg/dL).  While the 500 kcal exercise session did not elicit significant 
increases in HDL-C, there was a slight upward trend at the 48 hour (2 mg/dL) post-
exercise time point.  TG concentrations were also assessed, but no significant changes 
were elicited.  However, the accumulated exercise session did elicit a downward trend in 
TG concentrations from pre- to 24-hours post-exercise (31 mg/dL), and pre- to 48 hours 
post-exercise (25 mg/dL).  The single session of exercise did not cause any changes in 
post-exercise TG concentrations.  Even though TG concentration changes did not reach 
statistical significance, this study does support previous data suggesting accumulating 
exercise in a set pattern may be more effective in modifying lipid and lipoprotein 
concentrations compared to one session.  While this study does not directly match the 
Angelopoulos or Grandjean articles, it still provides insight to the effects of accumulating 
exercise in a set pattern. 
 Although the data on the acute augmented exercise response is limited, vital 
information is gained from these studies, listed in Table 4.  While each author utilized  
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Table 4 
The Effects of Acute Accumulated Sessions of Exercise on TG and HDL-C 
Concentrations 
 
Source Subj 
Study 
Design 
Int. (% 
max) 
Time 
(min) Kcal Session Timing TG HDL-C 
            
1        
Ex 
IPre 123 39 
          24HrP 48 1* 
Angelopoulos           48HrP 4 0 
et al., Int J 9M TM       
2        
Ex 
IPre 114 37 
Sports Med 22 1, 2, & 3 75 30 NR 24HrP -14 2* 
14: 196-201, UT bouts ex       48HrP 5 0 
1993 UT 48hr       
3        
Ex 
IPre 135 39 
            24HrP -28 4* 
            48HrP -5 1 
Biggerstaff 11F TM         Ipre 103 51 
et al., Res 25 3 bouts         24HrP -10 1 
Q Exerc ModT of ex 65 ~45 500   48HrP -10 1 
Sport 76(1):   48hr         96HrP -13 2* 
76, 2005             144HrP -20* 1 
Grandjean           Day 1 266 32 
et al., Med 15M TM         Day 2 -40* 0 
Sci Sport 50 4 cons. 70 NR 350 Day 3 -60* 2* 
Exerc 33(5): UT days of       Day 4 -59* 3* 
S215, 2001   ex 24hr       24HrP -80* 4* 
              72HrP -75* 6* 
Mestek et al., TM        
Cont. 
IPre 156 50 
Int J Sport 9M 1-500       24HrP -1 0 
Nutr & Ex 30 kcal 70 NR 500 48HrP -2 2 
Metabol 16: ModT       
Accum. 
IPre 159 49 
245-54, 2006    3-167       24HrP -31 5* 
      kcal       48HrP -25 7* 
Subjects: n = subject number; gender = Male (M) or Female (F); age in years; training 
status = Trained (T) or Untrained (UT). Mode: Treadmill (TM). Duration: minutes (min).  
Not Reported (NR). Timing: I = Immediate, P = Post, Ex = Exercise, Hr = Hour(s). TG = 
Triglycerides. HDL-C = High Density Lipoprotein-Cholesterol. Baseline lipids and 
lipoprotein-lipids are given as mg/dL, then mg/dL change from baseline.  
* Significantly different from baseline, P < 0.05. 
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different age groups, previous research indicates that age does not significantly impact 
post-exercise blood lipid changes.  These studies also utilized different exercise 
protocols, although the outcomes of each provide direction for this proposal.  The studies 
conducted by Angelopolous et al (1993), Biggerstaff et al. (2005)  indicate that 
performing three non-consecutive days of moderate intensity exercise can be more 
effective than one exercise session in reducing TG concentrations and concomitantly 
increasing (potentially significantly) HDL-C concentrations in young untrained or 
moderately trained individuals.  Findings by Mestek et al. (2006) support this finding 
even if total kcal expenditure is split into three sessions versus one continuous session.  
Most importantly, results from Grandjean et al. (2001-abstract) indicate that repeated 
bouts of exercise on successive days can produce an additive effect on raising HDL-C 
concentrations and lowering TG concentrations.  These exercise-induced changes in 
HDL-C and TG appear to persist for up to 3 days after the last exercise session.  This 
information supports the proposed exercise protocol, which implemented three successive 
days of exercise. 
 In summary, both single session and exercise training appear to improve an 
individual’s blood lipid profile, primarily by affecting HDL-C and TG concentrations.  
While this beneficial effect on blood lipid profile has not been shown in all experimental 
settings, the potential for modifying plasma lipid markers is indeed present.  This 
assumes that the exercise is of sufficient duration (e.g., >30 - 60 minutes), which appears 
to be based upon individual training levels.  It is believed that this exercise duration 
stimulates metabolic factors (i.e., LPL, CETP, and LCAT) which affect plasma lipid 
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concentrations.  However, the beneficial effects of lipid metabolism following an 
exercise session may be due to the acute response of the single session or a delayed 
response from multiple sessions is presently unknown.  Clearly, more work is necessary 
in order to ascertain the exact duration of exercise and proper exercise accumulation (i.e., 
frequency per week) required to produce the most optimal post-exercise blood lipid 
response.  Thereby effectively reducing the risks associated with the development of 
atherosclerosis and related CHD. 
 Based on the current state of lipid and lipoprotein knowledge, a direct comparison 
of a single session to accumulated sessions of exercise is needed.  While final data did 
not define the most optimal exercise duration or frequency, it tested an exercise 
recommendation (i.e., 90 minutes of moderate intensity) and assessed a specific exercise 
frequency (i.e., three consecutive days of exercise).  Results will be utilized for future 
exercise studies designed to investigate various elements of exercise dose (including 
exercise frequency) on blood lipid markers in how they relate to cardiovascular disease 
risk factors.
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CHAPTER III 
METHODS AND PROCEDURES 
 
 
 This chapter presents the methods that were used to investigate the effect of a single 
session compared to accumulated sessions of exercise, matched for time, on plasma lipid and 
lipoprotein concentrations.  It is organized according to the following subsections: Subjects, 
Pre-Study Screening, Maximal Exercise Testing, Submaximal Exercise Protocols, Dietary 
Records, Handling and Analysis of Blood Samples, and Statistical Analysis. 
 
Subjects 
 Twelve apparently healthy, sedentary subjects, males (n=6) and females (n=6) of 18-
26 years were recruited to participate in this study through both posted flyers (Appendix A) 
and via word of mouth.  Sample size was determined in order to observe statistically detected 
effect given 80% statistical power (Appendix B).  Because we expected the greatest subject 
variability to occur in the measurement of HDL-C concentration (females typically have 
higher HDL-C concentrations), this dependent variable was used in the power calculation. 
 Subjects were non-smokers and sedentary (e.g., performed less than one exercise 
session per week over the previous six months).  In addition, subjects had a resting blood 
pressure < 140/90mmHg and a waist circumference > 102 cm (males) or > 88 cm (females).  
Subjects were not using lipid or lipoprotein altering medications or supplements (e.g., fish oil 
capsules) during the six months leading up to participation in this study.  Only normally 
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menstruating females were allowed to participate in the study.  More specifically, only 
females who had three consecutive, normal length menstrual cycles were allowed to 
participate in the study.  Also, female subjects were not pregnant nor had they breastfed 
within the past six months prior to participation in the study.  A health history questionnaire 
(Appendix C), physical activity questionnaire (Appendix D), and informed consent 
(Appendix E) were completed by all subjects to determine eligibility. 
 Prior to participation, each subject was informed of all procedures, potential risks, 
and benefits associated with the study through both verbal and written form in accordance 
with the procedures approved by the University of North Carolina at Greensboro Institutional 
Review Board for Human Subjects Research. 
 
Pre-Study Screening 
 The researcher only conducted the following pre-study screening on potential subjects 
who reported that they were sedentary.  Potential subjects reported to the exercise physiology 
laboratory to have baseline assessments conducted.  Waist circumference was measured to 
the nearest half centimeter, a minimum of two times at the lateral border of the iliac crest, as 
described in The Third National Health and Nutrition Examination Survey (NHANES III) 
(NIH, 1998).  A third measurement was obtained if the first two measurements were not 
within + 1 cm.  Body weight was also measured at this session, to the nearest half kilogram.   
 During a 10-minute (seated) rest period subjects completed a health history 
questionnaire, physical activity questionnaire, and an informed consent.  After this 10-minute 
rest period, resting heart rate (HR) and blood pressure (BP) were assessed on both arms using 
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an automated blood pressure cuff (Omron, HEM-70SCP, Vernon Hills, IL) following the 
guidelines of the Seventh Report of the Joint Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (Chobanian et al., 2003).  Duplicate BP 
readings were taken from both arms in a rotating order (i.e., left, right, left, right).  If 
duplicate readings were not consistent (+5 mm Hg systolic, +3 mm Hg diastolic), a third 
reading was obtained and all data was averaged.  Also, if duplicate resting HR readings were 
not within +5 beats per minute, respectively, a third measurement was obtained and all data 
was averaged.  A 5-minute, 12-lead resting electrocardiogram (ECG) (Quinton Instruments 
Q3000, Seattle, WA) was then conducted to test for any heart abnormalities.  All subjects 
were required to have a medical release form (Appendix F) signed by a physician prior to 
their involvement in this study. 
 At the end of the pre-study screening, subjects were given three food diary data forms 
(Appendix N), along with serving size examples.  Subjects completed these dietary data 
forms (e.g., two weekdays and one weekend day) during the days leading up to their next 
laboratory visit.  All future dietary record information was provided to the subject at the end 
of each laboratory visit (as described in the Dietary Records section). 
 
Maximal Exercise Testing 
 Upon entering the exercise physiology laboratory, subjects were seated in a quiet 
environment for at least 10 minutes.  Following the 10-minute rest period, resting heart rate 
and blood pressure were measured by an automated blood pressure cuff (Omron, HEM-
70SCP, Vernon Hills, IL), utilizing the same procedures as described above.  Height and 
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weight were assessed using a Seca standiometer and a calibrated physician’s scale 
(DETECTO), respectively.  Additionally, body fat percentage was assessed via a three site 
skinfold test using Harpenden calipers (Creative Health Products, Ann Arbor, MI) via the 
technique described by Jackson and Pollock (1978) for male subjects and Jackson et al. 
(1980) for female subjects.  Male subjects had chest, abdominal, and thigh measurements 
taken, while female subjects’ had tricep, suprailiac, and thigh measurements taken.  All 
skinfold measurements were taken on the right side of the subjects’ body and performed a 
minimum of two times at each site by the same researcher.  The researcher rotated through 
the measurement sites in order to allow time for the skin to regain normal texture and 
thickness.  If the two measurements of each site were not within 2mm, a third measurement 
was taken.  The intra-site average was then calculated for each skinfold site.  Each site 
average was then added together to obtain a total skinfold thickness for all three sites.  This 
number was utilized for the determination of body density.  Based upon ethnicity, the proper 
percent body fat equation was utilized.  For Caucasian subjects, the Siri equation was utilized 
to convert body density to percent body fat as follows: % body fat = [(4.95/body density) – 
4.5] x 100.  For African-American male subjects, the Wagner & Heyward equation was 
utilized to convert body density to percent body fat as follows: % body fat = [(4.37/body 
density) – 3.93] x 100.  For African-American female subjects, the Ortiz equation was 
utilized to convert body density to percent body fat as follows: % body fat = [(4.85/body 
density) – 4.39] x 100.  Separate equations were utilized in order to account for the natural 
difference in bone density amongst different ethnicities (ACSM, 2009).  Therefore, the above 
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equations were utilized based upon ethnicity and age.  The form that was utilized for subject 
data collection is presented in Appendix G. 
 All graded maximal exercise tests were conducted in the Exercise Physiology 
Laboratory at The University of North Carolina at Greensboro.  Prior to the initiation of each 
test, both the flow meter and gas analyzers on the Ametek metabolic cart (Pittsburgh, PA), or 
Parvo Medics TrueOne® 2400 metabolic cart (Sandy, UT) were calibrated to known gases.  
Subjects who tested on a given cart remained on that cart throughout all exercise sessions.  
The environmental conditions in the laboratory [temperature and relative humidity using a 
Fisher Scientific® (Model: 11-661-13) digital readout (Pittsburgh, PA) and barometric 
pressure using a Precision barometer (Southhampton, PA)] were measured in order to 
standardize all metabolic measurements. 
 Prior to the initiation of the maximal exercise test a full explanation was given to each 
subject in regard to the rating of perceived exertion (RPE) scale (Appendix H).  This scale 
was utilized during the maximal test as an indicator of subject perceived exercise intensity.  
Heart rate and rhythm were monitored before, during, and following exercise testing via a 
twelve lead ECG.  Subjects were then fitted for a one-way valved mouthpiece, which was 
utilized for expired gas analysis.  A nose clip was then positioned in order to ensure no air 
escaped through the nose during testing procedures.  With the subject standing on the 
treadmill, heart rate and ECG tracings were recorded and blood pressure was monitored by 
auscultation utilizing a stethoscope and mercury sphygmomanometer. 
A maximal graded exercise test on a standardized institutional treadmill (Quinton 
Q55, Quinton Instruments, Seattle, WA) was then performed in order to determine maximal 
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oxygen consumption (VO2max).  The graded exercise protocol utilized was adaptable to an 
individual’s fitness level and designed to elicit volitional exhaustion within 8-12 minutes.  
Exercise was performed until one of the following occurred: subject could no longer continue 
due to fatigue, VO2max was achieved, technical difficulties, and/or subject showed signs or 
symptoms that indicate the test be terminated.  The criteria for achieving VO2max had to 
include at least two of the following: oxygen consumption plateau with an increased work 
rate, obtainment of + 10 beats per minute of age-predicted maximum heart rate (220-age), a 
respiratory quotient > 1.1.  During each two minute stage, heart rate, rhythm, VO2, 
respiratory quotient, and RPE were monitored and recorded (Appendix I). 
Following the test, subjects performed a cool-down period for several minutes until 
heart rate fell below 120 beats per minute or stabilized.  The peak (or max) VO2 value was 
determined by calculating the mean of the three highest consecutive twenty-second VO2 
values.  This VO2max value was utilized to calculate workload during the submaximal aerobic 
exercise protocols.  After the conclusion of this test, subjects were provided with study 
instructions and food diary data forms and, then scheduled for the remaining experimental 
visits.  A stepwise description of all maximal exercise procedures is provided in Appendix J. 
 
Submaximal Exercise Protocols 
 At the end of the maximal exercise laboratory visit all subjects received a detailed 
schedule outlining the time and dates of future exercise protocols.  Male subjects returned to 
the exercise physiology laboratory within one week, while females returned within the first 
seven days of their next menstrual cycle.  Subjects were instructed to maintain their 
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sedentary lifestyle throughout the length of data collection.  The weight of each subject was 
then obtained to determine any weight variations which may have occurred since the 
previous laboratory visit.  Following a 10-minute rest period, resting BP and HR data were 
collected (as described above).  Approximately 28mL of blood was obtained by a trained 
phlebotomist, and the same sterile procedures were used for all blood samples taken 
throughout the study.  A Polar heart rate monitor (Woodbury, NY) was then placed on the 
upper torso for determination of exercising heart rate and post-exercise assessment of 
average heart rate throughout the entire session.  
 Male subjects then performed all three exercise protocols in random order with at 
least one week in between the last and first day of each protocol.  Female subjects performed 
all three exercise protocols in random order with each protocol beginning within the first 
seven days of the menstrual cycle.  All treadmill exercise sessions were matched for time 
(e.g., 90 minutes). 
 As with the maximal aerobic exercise testing procedures, prior to each exercise 
protocol described below, both the flow meter and the gas analyzers on the metabolic carts 
were properly calibrated.  Also, the environmental conditions of the laboratory were analyzed 
and entered into the metabolic cart as previously indicated.  Subjects were also allowed to 
consume 4 ml/kg body weight of water every 30 minutes to help maintain hydration and 
plasma volume (Ferguson et al., 1998). 
The three experimental protocols are presented in Figure 4.  Protocol one required a 
single session of exercise followed by three days of post-exercise blood samples.  Protocol  
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Figure 4 
Experimental Protocols       
             
 
Protocol One: 
(Experimental) 
 
 
             
 
 
Protocol Two: 
(Experimental) 
 
 
             
 
 
Protocol Three: 
(Control) 
 
             
 
Experimental Protocols.  Protocol One required a blood sample (Blood, see above) prior to a 
single session of aerobic exercise (e.g., 90 minutes; see session #1 above) with additional 
blood samples taken every 24 hours post-exercise (e.g., 24 Hr PE) until 72 hours post-
exercise.  Protocol Two required subjects to accumulate three days of exercise (session #5, 
#6, and #7; 90 minutes per session), then assessed blood lipid concentration changes in the 
same time frame as Protocol One (i.e., 24, 48, and 72 hours post-exercise).  Within each of 
these two protocols, blood lipid concentrations were assessed from the pre-exercise time-
points to all other time-points.  Protocol Three (control) required two blood samples six days 
apart, equal to the number of days between the first and last session of protocol two.  These 
time-points provided information regarding any natural fluctuations which may have 
occurred during the same amount of time required to perform protocol two. 
 
 
two required three consecutive days of exercise, followed by three days of post-exercise 
blood samples after the third exercise session.  Protocol three acted as the control,  
requiring subjects to provide two blood samples separated by a six-day time period.  Each  
exercise session within a protocol required 90 minutes of exercise at a moderate intensity 
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(i.e., 60% VO2max).  The exercise intensity (60%VO2max) was at the upper end of the 
moderate intensity range, which is now widely recommended for the attainment of health-
related benefits.  The exercise duration (90 minutes) was selected to 1) be of sufficient 
duration to stimulate a post-exercise lipid and/or lipoprotein response, and 2) meet the 
criteria of a physical activity recommendation for obese individuals attempting to lose weight 
(Brooks et al., 2004).  Using these exercise parameters, this study directly assessed the post-
exercise blood lipid and lipoprotein responses to one session of exercise versus the 
accumulation of three sessions of exercise. 
 Similar to the maximal exercise test, subjects were breathing into a mouthpiece 
interfaced with the metabolic cart.  The beginning of each exercise session required the 
subject to walk at a comfortable pace for three minutes.  After this warm-up period, treadmill 
speed was increased until the heart rate range coinciding with 60% VO2max was achieved.  At 
the five minute mark gas analysis, via the metabolic cart, began.  Gas exchange was 
measured until 15 minutes of exercise was completed.  During this time, VO2 values were 
cross referenced with the subject’s VO2max information to ensure proper intensity (e.g., 60% 
VO2max).  While time of exercise was the primary goal of this study, caloric expenditure was 
also estimated as the product of the absolute oxygen consumption and the caloric equivalent 
for oxygen according to the specific respiratory exchange ratio (Park & Ransone, 2003).  
Caloric expenditure was calculated every fifteen minutes.  After caloric expenditure was 
calculated, the subject was then allowed to remove the mouthpiece and nose clip until the 
next 15-minute caloric expenditure reading.  During the time period when oxygen 
consumption was not being measured, exercise intensity was maintained at a constant level, 
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cross-referenced via heart rate and RPE.  Total energy expenditure was extrapolated from the 
15-minute oxygen consumption readings.  Heart rate was monitored throughout the entire 
test and utilized as a gauge of exercise intensity.  This process was conducted in order to 
continuously monitor caloric output while also allowing the subject to maintain a certain 
level of comfort, until 90 minutes of exercise was complete. 
Protocol One required subjects, in a single exercise session, to perform 90 minutes of 
treadmill exercise at 60% VO2max.  As previously indicated, prior to this exercise protocol 
a blood sample was obtained.  Additional blood samples were obtained 24, 48, and 72 hours 
post-exercise.  Protocol Two required three sessions of treadmill exercise at 60% VO2max.  
Each exercise session was separated by 24 hours and followed the same guidelines as 
previously described for Protocol One.  A pre-exercise blood sample was obtained prior to 
each exercise session, followed by 24, 48, and 72 hours after the third exercise session.  Each 
of the 90-minute exercise sessions in Protocols One and Two allotted two 5-minute rest 
periods (seated behind treadmill) between the three 30-minute exercise periods in order to 
ensure completion of each session and compliance with the protocols.  However, subjects 
could continue exercising if they did not require this allotted break.  Since intermittent 
exercise is advocated for health-related benefits, these brief periods of rest were not expected 
to affect the study’s results (Durstine et al., 2001; Quinn et al., 2006).  Protocol Three 
constituted the control trial, requiring no exercise with blood sampling at day one and day 
six, corresponding to the first and last days of Protocol Two.  Only two blood samples, rather 
than daily samples, were obtained in order to decrease the burden on the subjects and to 
increase compliance.  While daily samples would have been optimal, two samples still 
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allowed assessment of any non-exercise related fluctuations in plasma variables, particularly 
in female subjects as they advanced through the follicular phase of their menstrual cycle. 
 
Dietary Records 
 All subjects were instructed to maintain their normal pre-study diet during the study 
period and complete food diary data forms (Appendix N) to allow for nutrient intake 
assessment.  At the end of the pre-study screening visit to the laboratory, subjects were given 
three food diary data forms.  The same researcher provided instructions regarding portion 
sizes and recording of foods and beverages consumed.  Dietary records were kept for the 
three days prior to each exercise protocol (two weekdays and one weekend day).  Subjects 
continued to keep dietary logs throughout each day of all three protocols, ending the day 
before the final blood sample.  Records were analyzed for total calories, protein, 
carbohydrate, fat, and cholesterol (Diet Analysis Plus, Wadsworth Publishing Co., Salem, 
OR) (Table 6). 
 
Handling and Analysis of Blood Samples 
 Within each subject, all blood sampling occurred at approximately the same time of 
day (+ 1 hour).  Approximately 28 mL of blood were obtained with each sample, with a 
small portion being utilized to test hemoglobin (Drabkin et al., 1935) and hematocrit (Dill et 
al., 1974) levels.  The remainder of the blood sample was immediately centrifuged at 1,500 
rpm for 20 minutes at 4oC in a Beckman Coulter (Allegra 6KR) centrifuge (Palo, Alto, CA).  
Blood plasma was then pipetted into microcentrifuge tubes and stored at -80oC.  Plasma 
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samples were analyzed with a Bio-Tek (Powerwave 340, Winooski, VT) microplate for 
TCHL, LDL-C, HDL-C, and TG concentrations, using commercialized assays from Wako 
Chemicals USA Inc. (Richmond, VA) commercially prepared reagents.  All samples were 
assayed in triplicate on the first thaw.  Intrassay coefficients of variation were 2.4% for TG, 
1.6% for TCHL, and 2.7% for HDL-C.  To reduce the effects of interassay variations, all 
samples for a given subject were analyzed at the same time.  Interassay coefficients of 
variation were 2.6% for TG, 1.1% for TCHL and 5.8% for HDL-C.  
 
Statistical Analysis 
 The data obtained for TCHL, LDL-C, HDL-C, and TG were analyzed using a 
repeated measures analysis of variance (ANOVA).  Any significant effects were further 
analyzed via a paired sample t-test.  Direct comparisons of pre-exercise to all other time 
points were conducted, with an emphasis placed upon previous lipid and lipoprotein research 
(i.e., changes usually peak one-to-two days following a prolonged exercise session and these 
changes usually return to baseline by the third day) (Durstine et al., 2001).  Therefore, while 
a total of 12 blood draws/time points were conducted on each subject, a priori analyses 
allowed the researcher to compare the means of certain, predetermined time points both 
within each experimental protocol and across experimental protocols. 
The within treatment analyses compared the two exercise protocol blood lipid 
concentrations from the pre-exercise time-points to all other time-points in the same protocol.  
The control protocol required two blood samples six days apart, which was the same number 
of days between the first and last exercise session of protocol two (Figure 4).  These time-
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points provided information regarding any natural fluctuations which may occur during the 
same amount of time required to perform protocol two. 
The across treatment analyses compared each subject’s blood lipid concentrations 
across experimental protocols.  Concentration changes between baseline and the 24-, 48-, and 
72-hour post-exercise time-points were compared across the two exercise protocols.  Also, 
the differences in each of the lipid and lipoprotein variables across the control protocol were 
compared to the peak changes in the two exercise protocols.  This comparison assured that 
any changes in the exercise protocols took place due to exercise per se and not day-to-day 
variations.  All analyses were performed using SPSS statistical software (SPSS Inc., Chicago, 
IL).  Statistical significance was set at P < .05.  In addition, effect sizes were calculated and 
are reported as small (0 – 0.19), moderate (0.2 – 0.39), or large (>0.4). 
For comparison purposes the uncorrected [(U)] and corrected [(C)] (i.e., based upon 
plasma volume changes) experimental data (mg·dL-1) will be presented in tabular form.  For 
the repeated measures analysis of variance, Mauchly’s Test of Sphericity was first read to 
determine if the variances and covariances of the matrix were not significantly different.  If 
Mauchly’s Test was significant, the Hyunh-Feldt procedure was used.  However, if 
Mauchly’s Test was not significant, the Sphericity Assumed line was read to determine 
statistical significance.
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CHAPTER IV 
 
RESULTS 
 
 The results of this study are presented in the following sections: Subjects, Dietary  
Data, Submaximal Treadmill Sessions, Blood Variables, One Exercise Session Data, Three 
Exercise Sessions Data, Control Session Data, One Versus Three Exercise Sessions Data, 
and Average Post-Exercise Concentration Changes. 
 
Subjects 
 
 All twelve subjects (3 white males, 3 black males, 4 white females, 2 black females) 
met previously stated recruitment criteria.  Table 5 presents the subjects’ descriptive 
statistics.  As expected, above normal body mass indexes, percent body fat readings, and 
waist circumference readings were observed.  Male subjects displayed a higher body mass 
index compared to female subjects due to both greater lean and fat mass per height. 
 Subjects fell within the normal range for resting heart rate, systolic and diastolic 
blood pressure.  Male subjects had significantly higher resting systolic and diastolic blood 
pressure.  The subjects exhibited average to above average VO2max values, with no gender 
difference.  Although all subjects were abdominally obese, they still displayed normal 
aerobic fitness levels.  Also, while the specific aims of this study did not focus on race or 
gender, final results were not significantly affected by either of these variables.
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Table 5 
Descriptive Characteristics 
 
Variable 
All  
Subjects 
(n=12) 
Male    
(n=6) 
Female 
(n=6) 
White  
(n=7) 
Black   
(n=5) 
Age (years) 22.5 ± 2.5 22.8 ± 2.8 22.2 ± 2.5 22.6 ± 2.8 22.4 ± 2.4 
Height (cm) 171 ± 10 178 ± 4† 164 ± 9 169 ± 12 173 ± 7 
Weight (kg) 87.7 ± 19.3 104.6 ± 7.5‡ 70.8 ± 9.0 83.8 ± 22.4 93.1 ± 14.5 
BMI (kg·m-2) 29.7 ± 3.9 33.0 ± 2.1‡ 26.4 ± 1.8 28.7 ± 4.1 31.1 ± 3.7 
Body Fat (%) 24.6 ± 4.0 22.7 ± 3.9 26.6 ± 3.1 23.9 ± 3.5 25.7 ± 4.8 
Fat Body 
Mass (kg) 21.3 ± 4.4 23.7 ± 4.5 18.8 ± 3.0 19.5 ± 3.6 23.7 ± 4.7 
Lean Body 
Mass (kg) 66.4 ± 16.5 80.9 ± 6.7‡ 52.0 ± 7.5 64.3 ± 19.5 69.4 ± 12.8 
VO2max 
(ml·kg-1·min-1) 37.9 ± 5.5 36.7 ± 1.5 39.1 ± 7.7 40.0 ± 6.0 35.0 ± 2.9 
Waist Circ. 97.7 ± 9.5 106.6 ± 3.2‡ 88.9 ± 1.3 95.9 ± 9.6 100.2 ± 9.9 
Rest Heart 
Rate (bpm) 77.1 ± 6.4 79.5 ± 7.1 74.7 ± 5.0 75.4 ± 6.0 79.4 ± 6.8 
Rest Systolic 
BP (mmHg) 122.2 ± 14.1 134.5 ± 3.4‡ 109.8 ± 7.6 119.9 ± 13.7 125.4 ± 15.5 
Rest Diastolic 
BP (mmHg) 72.2 ± 6.6 76.2 ± 4.4* 68.2 ± 6.3 70.3 ± 6.8 74.8 ± 6.1 
Mean Arterial 
Pressure 88.7 ± 8.6 95.4 ± 3.3† 81.9 ± 6.5 86.6 ± 8.7 91.5 ± 8.5 
TCHL 203.5 ± 43.1 195.0 ± 24.1 212.0 ± 57.8 213.1 ± 48.5 190.0 ± 34.7 
LDL-C 129.5 ± 31.5 129.3 ± 22.4 129.6 ± 41.0 132.6 ± 33.4 125.1 ± 31.8 
TG 89.0 ± 25.6 94.9 ± 24.7 83.1 ± 27.4 92.2 ± 17.5 84.5 ± 36.1 
HDL-C 56.4 ± 17.9 46.5 ± 12.4* 66.2 ± 17.7 61.1 ± 20.7 49.7 ± 11.8 
Total/HDL-C 
Ratio 3.61 ± 1.0 4.19 ± 1.1 3.20 ± 0.7 3.49 ± 0.9 3.84 ± 1.3 
Values are means ± SD 
Lipid and lipoprotein concentrations are reported as mg/dL 
Different across gender (*p<.05; †p<.01; ‡p<.001) 
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Dietary Data 
 
 Each subject was required to record 22 days of dietary intake.  Subjects completed 
dietary logs for three days prior to the beginning of each experimental protocol, and through 
the end of the same protocol.  The average macronutrient intake of the first three days was 
utilized to establish pre-experiment (i.e., pre-average) levels.  Eight of the 12 subjects 
returned all dietary records, while four subjects failed to return a total of 10 days worth of 
dietary information.  For missing data, total averages were calculated from all other days 
within that experimental protocol and re-inserted for statistical analyses.  All values reported 
were considered adequate in accordance with the Recommended Dietary Allowances, and 
based on these self-reports it appears as though subjects were well nourished (Dietary 
Guidelines, 2005).  Repeated measures analysis of variance showed no significant 
differences across time for any measured dietary variable.  Final dietary information is 
presented in Table 6. 
 
Submaximal Treadmill Sessions 
 
 All subjects completed all aspects of the submaximal treadmill sessions.  Performance 
data collected during the submaximal exercise sessions are presented in Table 7.  While the 
60% VO2max intensity was a manageable brisk walk for most subjects, the duration of 90 
minutes presented a more challenging task.  In an attempt to minimize physical ailments 
(e.g., calf cramps, leg fatigue, heel blisters, etc.) several subjects required speed and grade 
modifications during the later minutes of the exercise duration.  These modifications required 
the researcher to change speed and/or grade in an attempt to ease these physical ailments,
 
 
 
 
Table 6 
Dietary Data Analysis (Control Session) 
 
Values are mean ± SEM 
Pre-average = average of the three days prior to Day 1 of the control session; CHO – Carbohydrate; PRO – Protein; CHL - 
Cholesterol. 
 
Variable Pre-average Day 1 Day 2 Day 3 Day 4 Day 5 
ANOVA 
Statistical 
Sign. 
Total Calories 1815.1 ± 111.1 2182.2 ± 247.9 1850.2 ± 164.2 1501.6 ± 169.8 2022.6 ± 146.2 1800.5 ± 216.5 p=.11 
CHO (%) 50.2 ± 2.6 50.5 ± 2.7 48.3 ± 2.9 48.8 ± 2.5 48.8 ± 3.6 47.1 ± 4.2 p=.91 
PRO (%) 18.5 ± 1.6 14.9 ± 1.5 15.9 ± 1.3 17.6 ± 1.4 19.1 ± 1.5 17.5 ± 1.8 p=.10 
Fat (%) 29.7 ± 1.9 36.6 ± 2.3 35.7 ± 2.2 34.9 ± 2.4 32.8 ± 2.6 33.0 ± 3.2 p=.15 
CHL (mg) 222.2 ± 24.3 229.3 ± 46.6 236.2 ± 36.2 181.1 ± 35.2 297.8 ± 59.1 349.1 ± 81.6 p=.11 
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Table 6 
 
Dietary Data Analysis (1 Exercise Session) (cont.) 
Variable  Pre-average Ex 1 24 PE 48 PE 
ANOVA 
Statistical 
Significance 
Total Calories 1470.8 ± 120.0 1767.1 ± 211.0 1900.9 ± 176.5 2019.6 ± 255.6 p=.14 
CHO (%) 48.8 ± 2.7 46.8 ± 5.4 47.7 ± 3.4 46.1 ± 3.2 p=.89 
PRO (%) 17.8 ± 1.1 20.8 ± 2.0 18.0 ± 1.9 19.3 ± 2.1 p=.40 
Fat (%) 35.4 ± 2.1 32.6 ± 3.3 34.2 ± 3.4 35.2 ± 2.5 p=.69 
CHL (mg) 189.7 ± 31.8 272.4 ± 74.9 215.6 ± 30.3 282.4 ± 41.7 p=.33 
Values are mean ± SEM 
Pre-average = average of the three days prior to the first laboratory visit of the 1-day of exercise experimental session; Ex 1 – 
Exercise session #1; 24PE – 24 hours post-exercise; 48PE – 48 hours post-exercise.  See page above for variable descriptors. 
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Table 6 
 
Dietary Data Analysis (3 Exercise Sessions) (cont.) 
Variable Pre-average Ex 1 Ex 2 Ex 3 24 PE 48 PE 
ANOVA 
Statistical 
Sign. 
Total Calories 1596.7 ± 143.4 1919.9 ± 315.7 1461.8 ± 158.9 1473.3 ± 301.0 1617.4 ± 162.0 1547.6 ± 157.6 p=.45 
CHO (%) 48.9 ± 3.0 53.3 ± 3.7 53.6 ± 4.1 51.9 ± 6.4 45.4 ± 6.5 46.9 ± 3.1 p=.48 
PRO (%) 19.1 ± 2.0 18.4 ± 1.9 17.1 ± 1.7 18.5 ± 3.2 22.4 ± 3.5 18.7 ± 2.0 p=.43 
Fat (%) 31.9 ± 1.9 30.5 ± 2.9 29.1 ± 3.1 30.6 ± 3.6 35.7 ± 2.1 33.0 ± 1.8 p=.44 
CHL (mg) 210.5 ± 34.4 229.8 ± 50.9 187.8 ± 42.3 173.7 ± 55.9 249.0 ± 51.2 182.6 ± 23.4 p=.70 
Values are mean ± SEM 
Pre-average = the average of the three days prior to the first laboratory visit of the 3-days of exercise experimental session.  
See page above for variable descriptors80 
 
 
 
 
Table 7 
Performance Data during Submaximal Treadmill Exercise 
 
Variable 
1 Exercise 
Session 
3 Exercise Sessions 
ANOVA 
Statistical Sign. 
Across Protocols Ex 1 Ex 2 Ex 3 
%VO2max 56.3 ± 1.5 57.3 ± 1.1 58.1 ± 1.2 57.5 ± 1.1 p=.22 
VO2       
(ml∙kg-1∙min-1) 21.1 ± 0.5 21.5 ± 0.6 21.8 ± 0.5 21.6 ± 0.6 p=.27 
Total kcal 
Expenditure 840.0 ± 66.9 840.8 ± 57.7 863.0 ± 63.6 844.3 ± 57.2 p=.50 
Kcal/kg 9.3 ± 0.3 9.6 ± 0.3 9.8 ± 0.2 9.6 ± 0.3 p=.18 
RER 0.903 ± 0.01 0.908 ± 0.01 0.893 ± 0.01 0.888 ± 0.01 p=.41 
Minute 
Ventilation (L) 124.2 ± 11.3 124.8 ± 11 127.2 ± 10 124 ± 10.4 p=.63 
Heart Rate 
(bpm) 149.9 ± 3.8 148.6 ± 3.5 145.3 ± 3 146.4 ± 3.1 p=.11 
RPE 12.9 ± 0.6 12.8 ± 0.6 12.9 ± 0.8 12.3 ± 0.7 p=.35 
Values are mean ± SEM 
RER = Respiratory Exchange Ratio, RPE = Rating of Perceived Exertion
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while also attempting to maintain the pre-determined exercise intensity range (i.e., 58-
62%VO2max).  However, some subjects could not maintain intensity throughout the entire 90 
minute treadmill session.  While final VO2max percentages were slightly below originally 
planned, values were not significantly below the desired range, they were not significantly 
different across any of the exercise sessions and can still be defined as being in the upper 
range of moderate intensity exercise.  Also, ratings of perceived exertion did not show any 
significant changes across exercise sessions.  No other physiological responses observed 
within or across exercise sessions were significantly different. 
 
Blood Variables 
 
 Plasma volume correction data from all three experimental sessions is presented in 
Table 8.  Pre and post-exercise hemoglobin and hematocrit concentrations were inserted into 
a corrective equation to obtain final plasma volume percent change (Greenleaf et al., 1979).  
Final plasma volume changes were within normal ranges, based upon past research 
(Convertino, 2007; Sawka et al., 2000). 
 
One Exercise Session Data 
 
 Specific Aim #1 addresses the comparison of the effects of a single 90-minute 
treadmill exercise session performed at 60% VO2max versus no exercise (control group) on 
lipid and lipoprotein concentrations in young, sedentary obese adults.  While the two 
working hypotheses focus only on TG and HDL-C concentration changes, all variable results 
will be presented in both uncorrected (i.e., not corrected for plasma volume change) and 
 
 
 
 
Table 8 
Plasma Volume Correction Data 
 
Variable PreC PstC 
Hemoglobin (g/dL) 17.4 ± 0.4 17.5 ± 0.3 
Hematocrit (%) 46.7 ± 0.7 46.5 ± 0.7 
Plasma Volume Δ (%) 0.17 ± 0.5 
 
Variable Ex1 Ex1-24 Ex1-48 Ex1-72 
Hemoglobin (g/dL) 17.1 ± 0.3 17.2 ± 0.3 17.1 ± 0.3 17.4 ± 0.4 
Hematocrit (%) 46.6 ± 0.5 45.6 ± 0.7 46.7 ± 0.8 46.5 ± 0.7 
Plasma Volume Δ (%) 1.38 ± 0.4 -0.11 ± 0.6 -1.41 ± 0.5 
 
Variable Ex3-1Pre Ex3-2Pre Ex3-3Pre Ex3-24 Ex3-48 Ex3-72 
Hemoglobin (g/dL) 18.0 ± 0.4 17.7 ± 0.3 17.4 ± 0.4 16.6 ± 0.3 16.7 ± 0.4 16.6 ± 0.3 
Hematocrit (%) 45.0 ± 0.7 44.8 ± 0.7 45.8 ± 0.9 45.9 ± 0.9 44.5 ± 0.8 44.4 ± 0.8 
Plasma Volume Δ (%) 1.97 ± 0.5 1.79 ± 0.6 6.64 ± 0.5 8.69 ± 0.5 9.18 ± 0.5 
Values are mean ± SEM 
PreC – Pre Control; PstC – Post Control; Ex1 – 1 exercise session; Ex3 – 3 exercise sessions; 1Pre – prior to exercise session 
#1; 2Pre – prior to exercise session #2; 3Pre – prior to exercise session #3; 24 – 24 hours post-exercise; 48 – 48 hours post-
exercise; 72 – 72 hours post-exercise
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corrected (i.e., corrected for plasma volume change) form.  Moreover, the Statistical Analysis 
section of chapter three specifically states, “The within treatement a priori analyses for each 
of the two exercise protocols will be the comparison of blood lipid concentrations from the 
pre-exercise time-points to all other time-points in the same protocol.”  Therefore, a repeated 
analysis of variance was conducted to assess blood concentration differences within each 
exercise protocol.  If any ANOVA statistical significance was noted, a subsequent post-hoc t-
test was conducted to determine exact time-point significance. 
 Final data for the one exercise session protocol are presented in Table 9.  Only the 
uncorrected total cholesterol variable indicated a statistical difference over time.  However, 
when total cholesterol was corrected for plasma volume changes there was no significant 
time effect. 
 
Three Exercise Sessions Data 
 
 The results of the three exercise sessions data are presented in the same manner as the 
results of the one exercise session data.  The Statistical Analysis section of chapter three 
specifically states, “The within treatement a priori analyses for each of the two exercise 
protocols will be the comparison of blood lipid concentrations from the pre-exercise time- 
points to all other time-points in the same protocol” (see page 72).  Therefore, a repeated 
analysis of variance was conducted to find any across treatment blood concentration 
differences within each exercise protocol.  If any ANOVA statistical significance was noted, 
a subsequent post-hoc t-test was performed to determine exact pre/post time-point 
significance. 
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Table 9 
One Exercise Session Data 
 
Variable 
(mg∙dL-1) IPreEx 24PEx 48PEx 72PEx 
ANOVA 
Statistical 
Sign. 
TCHL (U) 
TCHL (C) 
207.5 ± 13.8 
207.5 ± 13.8 
195.0 ± 14.6† 
198.1 ± 15.2 
197.0 ± 12.7* 
197.0 ± 13.2 
198.8 ± 16.4 
196.5 ± 16.4 
p=.02 
p=.07 
LDL-C (U) 
LDL-C (C) 
134.7 ± 10.3 
134.7 ± 10.3 
117.7 ± 7.1 
119.7 ± 7.7 
118.9 ± 9.1 
118.9 ± 9.3 
126.5 ± 12.4 
124.9 ± 12.3 
p=.10 
p=.13 
TG (U) 
TG (C) 
86.8 ± 7.9 
86.8 ± 7.9 
79.2 ± 12.1 
80.3 ± 12.2 
89.8 ± 10.9 
90.0 ± 11.2 
87.9 ± 10.1 
86.7 ± 10.1 
p=.52 
p=.63 
HDL-C (U) 
HDL-C (C) 
55.9 ± 5.3 
55.9 ± 5.3 
53.9 ± 5.1 
54.8 ± 5.3 
52.3 ± 5.2 
52.3 ± 5.2 
54.7 ± 5.1 
54.2 ± 5.1 
p=.10 
p=.10 
Values are averages ± SEM 
U – Uncorrected for plasma volume change; C – Corrected for plasma volume change; 
IPreEx – Immediately pre-exercise; 24PEx – 24 hours post-exercise; 48PEx – 48 hours post-
exercise; 72PEx – 72 hours post-exercise; ANOVA – Analysis of variance 
* Different from Immediately Pre-Exercise (p<.05). 
† Different from Immediately Pre-Exercise (p<.01). 
 
 
 The uncorrected data showed a significant decrease in TG concentrations, but the 
plasma volume corrected TG data was not significant.  Although not significant (p=.06), the 
corrected TG data showed a similar decreasing trend from exercise session #1 through 24 
hours post-exercise, with a return toward baseline over the next two days.  Also, there was a 
near significant (.06) decrease in TCHL from exercise session #1 through exercise session 
#3, which was due mostly to a drop in very low density lipoprotein concentrations.  After 
plasma volume correction HDL-C concentrations were significantly elevated 24 and 48 hours 
post-exercise [moderate effect (.31)].  Final data for the three exercise sessions protocol are 
presented in Table 10. 
 
 
 
 
 
Table 10 
Three Exercise Sessions Data 
 
Variable 
(mg·dL-1) IPreEx-1 IPreEx-2 IPreEx-3 24PEx 48PEx 72PEx 
ANOVA 
Statistical 
Sign. 
TCHL (U) 
TCHL (C) 
200.7 ± 12.9 
200.7 ± 12.9 
191.8 ± 14.7 
195.6 ± 15.3 
185.5 ± 10.0 
188.6 ± 10.1 
190.8 ± 12.6 
202.8 ± 13.2 
189.9 ± 10.5 
206.7 ± 12.2 
185.6 ± 10.9 
202.8 ± 12.6 
p=.14 
p=.06 
LDL-C (U) 
LDL-C (C) 
126.0 ± 8.4 
126.0 ± 8.4 
122.5 ± 11.3 
124.9 ± 11.7 
119.9 ± 8.2 
121.9 ± 8.3 
123.9 ± 10.3 
131.6 ± 10.7 
121.6 ± 8.3 
132.4 ± 9.6 
118.0 ± 10.1 
129.1 ± 11.6 
p=.57 
p=.28 
TG (U) 
TG (C) 
90.0 ± 10.3 
90.0 ±10.3 
76.0 ± 10.2 
77.9 ± 10.9 
66.5 ± 4.5* 
67.6 ± 4.5 
60.4 ± 6.7* 
64.3 ± 7.1 
68.8 ± 7.6 
75.1 ± 8.9 
71.9 ± 8.6 
78.5 ± 9.4 
p=.03 
p=.06 
HDL-C (U) 
HDL-C (C) 
55.5 ± 6.0 
55.5 ± 6.0 
53.4 ± 5.1 
54.4 ± 5.2 
52.3 ± 4.4 
53.2 ± 4.4 
55.4 ± 5.3 
58.9 ± 5.7* 
54.5 ± 5.3 
59.2 ± 5.7* 
53.8 ± 5.2 
58.7 ± 5.6 
p=.31 
p=.00 
Values are averages ± SEM 
U – Uncorrected; C – Corrected; IPreEx-1 – Immediately pre-exercise session #1; IPreEx-2 – Immediately pre-exercise session 
#2; IPreEx-3 – Immediately pre-exercise session #3; 24PEx – 24 hours post-exercise; 48PEx – 48 hours post-exercise;    
72PEx – 72 hours post-exercise; ANOVA – Analysis of variance 
* Different from Immediately Pre-Exercise Session #1 (p<0.05).
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Control Session Data 
 
 The control session data (mg·dL-1) is presented in Table 11.  No significant differences 
were noted between pre and post-control plasma concentrations for any blood variable. 
 
One Exercise Session Versus Three Exercise Sessions Data 
 
 Specific aim #3 addresses the comparison of the effects of a single 90-minute 
treadmill exercise session performed at 60% VO2max versus three 90-minute exercise sessions 
performed at 60% VO2max on lipid and lipoprotein concentrations in young, sedentary obese 
adults.  The two working hypotheses focus on how three consecutive days of accumulated 
exercise will produce greater improvements in plasma TG and HDL-C concentrations 24-72 
hours after the last session of exercise, compared to the improvements observed 24-72 hours 
after a single session of exercise.  Even though the two working hypotheses focus only on 
TG and HDL-C concentration changes, the results for TCHL and LDL-C are also presented.  
Data is presented after corrected for plasma volume change.   
 The Statistical Analysis section specifically states, “The across treatement a priori 
analyses will compare each subject’s blood lipid concentrations across experimental 
protocols.  Concentration changes between baseline and the 24-, 48-, and 72-hour post- 
exercise time-points will be compared across the two exercise protocols.  This will indicate 
whether or not the two additional exercise sessions in protocol two resulted in greater blood 
lipid concentration changes.”  Therefore, a 2 X 4 repeated measures analysis of variance was  
Table 11 
Control Session Data 
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Variable (mg·dL-1) Pre-Control Post-Control 
t-test 
Statistical 
Sign. 
TCHL (U) 
TCHL (C) 
202.2 ± 13.0 
202.2 ± 13.0 
195.4 ± 12.5 
196.4 ± 14.0 
p=.12 
p=.23 
LDL-C (U) 
LDL-C (C) 
127.7 ± 10.2 
127.7 ± 10.2 
118.4 ± 11.7 
119.4 ± 12.9 
p=.09 
p=.18 
TG (U) 
TG (C) 
85.0 ± 9.8 
85.0 ± 9.8 
102.9 ± 8.5 
103.2 ± 8.7 
p=.11 
p=.09 
HDL-C (U) 
HDL-C (C) 
57.7 ± 4.7 
57.7 ± 4.7 
55.7 ± 4.2 
55.7 ± 4.2 
p=.18 
p=.14 
Values are average ± SEM 
U – Uncorrected for plasma volume change; C – Corrected for plasma volume change 
 
 
conducted to assess blood concentration differences across the two exercise protocols.  Final 
data for the three exercise sessions protocol are presented in Figure 5. 
 A repeated measures analysis of variance indicated a significant treatment by time 
difference for LDL-C [moderate effect (.24)].  However, the post-hoc t-test did not show any 
specific timepoint differences.  Also, there was a significant treatment x time difference for 
HDL-C.  The post hoc t-test indicated a difference between the two exercise sessions 48 
hours post-exercise [moderate effect (.29)]. 
 
Average Post-Exercise Concentration Changes 
 
 The statistical analysis section (see page 72) indicates that peak post-exercise changes 
in the two exercise protocols would be compared to the control protocol.  For the two 
exercising protocols the average of the three post-exercise concentrations were analyzed 
Figure 5 
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One Versus Three Exercise Sessions Means ± SEM 
 
  
 
Values are mean ± SEM 
Pre – pre exercise session #1; 24-Post – 24 hours post-exercise; 48-Post – 48 hours post-
exercise; 72-Post – 72 hours post-exercise 
Only upper and lower confidence intervals are shown 
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 (p<.05)
175
180
185
190
195
200
205
210
215
220
Pre 24-Post 48-Post 72-Post
To
ta
l C
ho
le
st
er
ol
 (m
g·
dL
-1
)
1Ex
3Ex
105
110
115
120
125
130
135
140
145
Pre 24-Post 48-Post 72-Post
LD
L-
C
 (m
g·
dL
-1
)
1Ex
3Ex
50
60
70
80
90
100
110
Pre 24-Post 48-Post 72-Post
Tr
ig
ly
ce
rid
es
 (m
g·
dL
-1
)
1Ex
3Ex
45
47
49
51
53
55
57
59
61
63
65
Pre 24-Post 48-Post 72-Post
H
D
L-
C
 (m
g·
dL
-1
)
1Ex
3Ex
*
 
90 
 
 
because not all post-exercise time-points peaked in the same direction.  Therefore, a 2 X 3 
ANOVA was conducted to compare pre versus post-exercise average for the two 
experimental protocols and pre versus post-control for the control protocol. 
 The results for the average post-exercise concentration changes are presented in 
Figure 6.  A significant decrease in LDL-C was observed from pre-exercise to post-exercise 
average for the single exercise session [moderate effect (.31)].  A significant elevation was 
observed for HDL-C from pre- to post-exercise average for the three exercise session 
protocol, and the post three exercise sessions’ average change was significantly elevated 
compared to the post one exercise session average change [moderate effect (.39)]. 
 The results observed in Figure 6 did not account for differing baseline lipid 
concentrations across treatments.  Therefore, percent change scores were derived by 
subtracting the pre-exercise concentrations from the post-exercise average concentrations and 
then dividing the difference by the pre-exercise concentrations.  A repeated measures 
ANOVA was conducted followed by paired samples t-tests.  A significant percentage change 
between the two exercising protocols resulted with LDL-C [moderate effect (.29)].  Also, 
regarding the percentage changes in TG, there was a significant difference between the 
control protocol and the three exercise session protocol [moderate effect (.25)].  Finally, 
HDL-C showed significant percent change differences for the three exercise session protocol 
compared to the control and single exercise session protocols [large effect (.4)] (Figure 7). 
 The TG findings reported in Figure 7 were unexpected because, while the three 
exercise session protocol elicted a beneficial 17% decrease (i.e., pre- versus post-exercise), 
the control session resulted in an 18% increase in TG concentration.  To further explore this
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Figure 6 
Average Post-Exercise Concentration Changes Means ± SEM 
 
 
 
Pre – pre exercise session #1; PExAvg – post-exercise average 
* LDL-C = Different from Pre1 vs. Post 1-Exercise Session Average (p<.05) 
* HDL-C = Different from Pre3 vs. Post 3-Exercise Sessions Average (p<.05) 
** HDL-C = Different from Post1 vs. Post 3-Exercise Sessions Average (p<.05) 
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Figure 7 
Pre Versus Peak Post-Exercise Percentage Changes Means ± SEM 
  
  
CON – control; 1Ex – 1 exercise session; 3Ex – 3 exercise sessions 
* LDL-C – Different from 1Ex vs. 3Ex (p<.05) 
* Triglycerides – Different from Control vs. 3Ex (p<.05) 
* HDL-C – Different from 1Ex vs. 3Ex (p<.05) 
** HDL-C – Different from Control vs. 3-Ex (p<.05) 
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finding, a Pearson Product Moment correlation analysis was conducted (pre-exercise 
concentration versus percent change) to determine if TG change was affected by baseline 
concentrations.  Regarding the three exercise session protocol, subjects with the highest 
baseline concentrations experienced the greatest post-exercise TG reductions (r = -0.655, p = 
.021) (Figure 8).  Secondly, a separate correlational analysis indicated that subjects with 
lower pre-control concentrations experienced the highest increase in TG across the control 
treatment (r = -0.593, p = .042) (Figure 9). 
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Figure 8 
Triglycerides Percentage Change Post-hoc Analysis (3 Exercise Sessions) 
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Figure 9 
Triglycerides Percentage Change Post-hoc Analysis (Control Session) 
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CHAPTER V 
 
DISCUSSION AND CONCLUSIONS 
 
Two factors associated with cardiometabolic risk are decreased HDL-C and increased 
TG plasma concentrations.  Exercise has been shown to concomitantly increase HDL-C and 
decrease TG (Durstine & Haskell, 1994).  While past research indicates that these beneficial 
changes can occur due to exercise training, studies employing single prolonged sessions of 
exercise have produced similar results that last one to three days after exercise.  However, 
current research has not defined the potential interaction between the acute and training 
responses (Haskell, 1994).  Specifically, accumulating the effects of single sessions of 
exercise may produce an additive post-exercise effect on plasma lipid concentrations beyond 
those observed after a single session of exercise.  Therefore, the purpose of the present study 
was to compare three experimental protocols: 1) a single exercise session, 2) identical 
prolonged exercise sessions performed on three consecutive days, and 3) a control period 
with no exercise.  The duration of each moderate-intensity exercise session (90 minutes) 
reflects a recent physical activity recommendation for obese individuals attempting to lose 
weight (Brooks et al., 2004). 
In order to assess blood cholesterol transport changes, HDL-C, TG, TCHL, and LDL-
C were measured.  Based upon previous literature, HDL-C and TG concentrations were the 
two variables most expected to change following exercise (Durstine et al., 1994; Thompson 
et al., 2001).  For this reason, the working hypotheses of this dissertation focused on these 
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two variables.  Since the results of HDL-C and TG differed, each working hypothesis of this 
dissertation will be addressed in relation to HDL-C first, and then TG.  Although TCHL and 
LDL-C were not included in the hypotheses, they will still be discussed.  To our knowledge, 
this is the first investigation to compare single versus accumulated exercise sessions on post-
exercise lipid and lipoprotein changes utilizing both male and female subjects. 
 
HDL-C Concentrations 
 
 A single 90-minute session of moderate intensity exercise, resulting in ~850 
kilocalories of energy expenditure, did not induce a significant elevation of HDL-C 
concentration.  Therefore, the hypothesis indicating that a single session of exercise would 
produce improved HDL-C concentrations compared to the control group is rejected. 
 While most of the existing single session exercise literature supports a post-exercise 
increase in HDL-C (Bounds et al., 2000; Crouse et al., 1995; Crouse et al., 2001; Ferguson et 
al., 1998; Grandjean et al., 2000; Kantor et al., 1984), some studies report no change or even 
reduced concentrations.  Swank et al. (1987) recruited young, trained, normal weight females 
to perform a 40-minute treadmill run at 70% VO2max.  No significant HDL-C concentration 
changes were reported 24, 48, or 96 hours post-exercise.  Davis et al. (1992) required young, 
trained, lean males to perform a 90-minute treadmill run at 50% VO2max.  No significant 
HDL-C concentration changes were found 24 through 72 hours post-exercise.  Frey et al. 
(1993), who required young, lean, well-trained males to perform a 30 kilometer run (~130 
minutes) at an average of 78% VO2max, reported no significant HDL-C concentration changes 
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20 hours post-exercise.  While these studies found no HDL-C concentration changes utilizing 
subjects who were leaner and more trained, they were similar in age to the current study. 
 In addition to research conducted with trained individuals, studies conducted on 
young, sedentary individuals also support the current study’s findings.  Angelopoulos and 
colleagues (1993) assessed young, overweight, sedentary males and reported no HDL-C 
change 24 or 48 hours after a 30-minute treadmill run at 65% VO2max.  Imamura et al. (2000) 
noted no significant post-exercise HDL-C concentration changes 24 hours after 60 minutes 
(~322 kilocalorie average) of cycle ergometry work at 60% VO2max in sedentary, lean young 
women.  It is possible that these studies did not yield significant changes due to their lower 
exercise volume.  However, a study utilizing a single exercise session protocol similar to that 
of the current study was conducted by Tsetsonis & Hardman (1995) who reported no post-
exercise (24 hours) HDL-C concentration changes after requiring young, untrained, normal 
weight men and women to perform 90 minutes of treadmill exercise at 60% VO2max.  More 
recently, Wooten et al. (2008) showed a significantly decreased HDL-C concentration 48 
hours after sedentary, overweight, young men performed a 500 kilocalorie treadmill session 
at 65% VO2max. 
 Although the above studies support the current study’s findings that HDL-C was not 
increased after young, sedentary individuals performed a single moderate intensity exercise 
session lasting up to 90 minutes, other studies utilizing similar subjects and exercise 
protocols have yielded significantly elevated HDL-C concentrations (Kantor et al., 1987; 
Park & Ransone, 2003).  As such, the 90-minute exercise duration of the current study was 
developed based upon this previous research showing HDL-C elevations and upon a current 
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exercise recommendation advocated for weight management (Brooks et al., 2004).  
Specifically, past research has elicited HDL-C elevations after an acute exercise session 
requiring 350 to 500 kilocalories (Durstine et al., 2001; Thompson et al., 2001).  These 
findings suggest that a minimum energy expenditure threshold must be met in order to 
stimulate elevated HDL-C concentrations.  However, this suggested minimal threshold may 
vary based upon subject characteristics (i.e., age, training status, baseline cholesterol 
concentrations, body composition, etc.). 
 The following studies conducted on sedentary individuals support the potential to 
elevate HDL-C concentrations after an acute exercise session requiring between 350 to 500 
kilocalories.  Park & Ransone (2003) noted significant HDL-C elevations 24 hours after 
requiring young, sedentary, normal weight (normocholesterolemic) males to perform a 350 
kilocalorie treadmill session at lactate threshold.  Crouse et al. (1995) required middle-aged, 
hypercholesterolemic, sedentary, overweight males to perform two separate 350 kilocalorie 
cycle ergometer exercise sessions (50% VO2max or 80% VO2max).  HDL-C was significantly 
elevated 24 through 48 hours after each exercise session.  Another study by Crouse et al. 
(1997) reported significant HDL-C elevations 24 through 48 hours after requiring middle-
aged, overweight, hypercholesterolemic males to perform a 350 kilocalorie cycle ergometer 
session at 50% VO2max.  These studies suggest that sedentary, overweight males can elicit 
significant post-exercise HDL-C concentration elevations after performing a relatively low-
volume exercise session.  It does not suggest that only men can produce changes, because 
past research indicates that no gender differences exist (Tsetsonis & Hardman, 1995). 
 
100 
 
 
 A study directly comparing normocholesterolemic to hypercholesterolemic 
individuals provides further support that a low volume exercise duration can elicit HDL-C 
elevations.  Grandjean and colleagues (2000) required middle-aged, sedentary, overweight, 
normocholesterolemic and hypercholesterolemic men to perform a 500 kilocalorie treadmill 
walk at 70% VO2max.  HDL-C was elevated 24 and 48 hours post-exercise for both 
normocholesterolemic (14%) and hypercholesterolemic (11%) men.  Compared to the current 
study, this study elicited HDL-C elevations utilizing a shorter exercise duration on sedentary 
subjects exhibiting similar baseline HDL-C concentrations (for normocholesterolemic 
subjects) and body composition. 
 A study conducted by Crouse et al. (2001-abstract) required sedentary middle-aged 
men (body weight was not reported) to perform a 500 kilocalorie treadmill session at 60-70% 
VO2max.  Prior to initiation of this study, subjects were screened into moderate (~50 mg/dL) 
or low (~35 mg/dL) baseline HDL-C concentrations (TCHL concentrations were not 
reported).  Both groups noted a significant HDL-C increase (9%) 24 and 48 hours post-
exercise.  The moderate baseline values reported were comparable to the current study’s 
subjects (~56 mg/dL).  Compared to the current study, this study reported elevated HDL-C 
concentrations utilizing a shorter exercise duration on sedentary individuals exhibiting 
similar baseline HDL-C concentrations. 
 The above studies suggest that some individuals, independent of baseline TCHL or 
HDL-C, can elicit HDL-C concentration elevations with an exercise duration requiring 350 
to 500 kilocalories.  However, these findings may only be applicable to middle-aged or older 
individuals.  Therefore, while researchers have suggested that an exercise duration requiring 
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350 to 500 kilocalories may be sufficient to induce significant post-exercise plasma volume 
corrected HDL-C elevations (Thompson et al., 2001), the current study, which required ~850 
kilocalorie energy expenditure, does not support this notion. 
 Beyond the effects of a single session of exercise, a very limited amount of research 
has attempted to assess a potential accumulated effect of repeated sessions of exercise on 
plasma lipid and lipoprotein concentrations (Grandjean et al., 2001; Thompson et al., 2001).  
The results of the current study provide support for an additive effect of three consecutive 
daily sessions of exercise.  HDL-C concentrations were statistically elevated 24 and 48 hours 
after performing three sessions of exercise when compared to the change across time in the 
control session.  These findings lead to the acceptance of the hypothesis that three sessions of 
exercise will produce improved HDL-C concentrations post-exercise compared to the control 
group.  Also, when comparing post-exercise concentration changes between the two exercise 
protocols (one day of exercise versus three consecutive days of exercise), a significant time 
by trial interaction was observed with HDL-C elevated at the 48 hour timepoint following the 
three-day trial (Figure 5).  This finding leads to the acceptance of the hypothesis that three 
consecutive sessions of exercise will produce greater post-exercise improvements in HDL-C 
compared to one session of exercise. 
 Furthermore, the a priori analysis was to compare the peak changes across the two 
exercise protocols and control session.  This was conducted by assessing baseline 
concentrations compared to the average post treatment change [i.e., average of 24, 48, and 72 
hour timepoint concentrations (“peak” concentrations could not be assessed because 
timepoints changed in differing directions for some variables)].  The treatment by time 
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ANOVA indicated significant concentration elevations from 1) pre-three sessions of exercise 
versus post-three sessions of exercise, and 2) post-three sessions of exercise versus post-one 
session of exercise (Figure 6).  Lastly, a repeated measures ANOVA indicated a percentage 
change (i.e., pre versus post-average) for HDL-C concentrations when comparing the three 
sessions of exercise to both the control and one session of exercise (Figure 7).  Taken 
together, these results indicate that performing prolonged moderate intensity exercise for 
three consecutive days is more effective in elevating HDL-C concentrations than one session 
of exercise or no exercise. 
 Currently there are only three studies that specifically assess the accumulated effects 
of exercise on HDL-C concentrations.  Angelopoulos et al. (1993) recruited young, 
sedentary, overweight males to perform three separate exercise protocols: 1) one session, 2) 
two sessions, with 48 hours separation, and 3) three sessions, each with 48 hours separation.  
All treadmill exercise sessions were 30 minutes at 65% VO2max.  HDL-C concentrations were 
significantly higher 24 hours post-exercise, before returning to baseline by 48 hours post-
exercise, after all three sessions.  As previous research has suggested, the quick return to 
baseline concentrations 48 hours post-exercise, for all three exercise sessions, may be related 
to the short exercise duration (Durstine et al., 1994; Thompson et al., 2001).  By 
implementing an ~850 kilocalorie exercise output, the current study observed longer post-
exercise HDL-C concentration elevations. 
 More recently, Biggerstaff et al. (2005 - abstract) described a three exercise session 
protocol, each session separated by 48 hours.  Young, moderately active, overweight women 
performed treadmill exercise for 500 kilocalories at 65% VO2max.  HDL-C concentrations 
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statistically increased prior to the third session of exercise, but had returned to baseline 
concentrations 48 hours post-exercise (compared to a resting protocol).  The elevated 
timepoint prior to the third session of exercise did not exactly match the current study’s 
significant elevation (timepoint 24 and 48 hours after the third session of exercise).  This 
different response pattern may be due to differing periods of time between the three sessions 
of exercise (48 versus 24 hours, respectively). 
 Also, Grandjean et al. (2001 - abstract) utilized hyperlipidemic, middle-aged, obese 
men for assessment of a 350 kilocalorie treadmill protocol at 70% VO2max.  Similar to the 
findings of the current study, one session of exercise did not elicit a change in HDL-C 
concentration.  However, exercising on four consecutive days induced an additive effect on 
raising HDL-C concentrations.  Two days of exercise were required before HDL-C 
concentrations were significantly elevated.  Then concentrations held steady through the 
fourth day of exercise and continued to increase 24 and 72 hours post-exercise (a 48 hour 
post-exercise time point was not collected).  The current study found similar HDL-C 
elevations after three consecutive sessions of exercise, but utilized younger participants 
(including females) who exhibited lower TCHL and higher HDL-C baseline concentrations.  
Taken together, these findings suggest that neither age nor baseline concentrations prevent an 
individual from improving HDL-C after performing three or four repeated sessions of 
exercise. 
 In summary, the results of this study and those previously investigating the 
accumulated effects of several days of exercise indicate that post-exercise HDL-C elevations 
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are affected by the amount of exercise performed and/or manner in which the exercise 
sessions are repeated (i.e., every day versus every other day). 
 
TG Concentrations 
 
 A single 90-minute session of moderate intensity exercise, resulting in ~850 
kilocalories of energy expenditure, did not induce statistically significant post-exercise TG 
concentration changes.  Therefore, the hypothesis stating that a single session of exercise will 
improve post-exercise TG concentrations compared to the control session, is rejected. 
 Much of the existing acute exercise TG literature reports significant post-exercise 
reductions (Durstine et al., 2001; Thompson et al., 2001).  In particular, individuals with 
elevated baseline TG concentrations typically show the greatest, and most consistent, post-
exercise decreases, while individuals with lower baseline TG concentrations do not show 
reductions as often.  Studies with participants having baseline concentrations >125 mg/dL 
have consistently reported decreases in TG concentrations (Crouse et al., 1995; Crouse et al., 
1997; Crouse et al., 2001; Grandjean et al., 2000). 
 While some acute studies have failed to yield reduced TG concentrations on the days 
following exercise, most of these have involved trained participants (Davis et al., 1992; 
Gordon et al., 1998; Hughes et al., 1990) or have employed relatively low volumes of 
exercise (<60 minutes, <70% VO2max) (Angelopoulos et al., 1993; Imamura et al., 2000; 
Lennon et al., 1993; Swank et al., 1987; Tsetsonis & Hardman, 1995).  On the other hand, 
some studies have reported post-exercise reductions in sedentary individuals with baseline 
TG concentrations comparable to those of the current study (90 mg/dL).  Wooten et al. 
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(2008) showed significantly reduced TG 48 hours after young, sedentary, overweight 
(baseline TG=103 mg/dL) men performed a 500 kilocalorie treadmill session at 65% VO2max.  
Another study by Crouse et al. (2001-abstract) required sedentary middle-aged men to 
perform a 500 kilocalorie treadmill session at 60-70% VO2max.  Prior to initiation of this 
study, subjects were stratified into moderate (~103 mg/dL) or elevated (~190 mg/dL) 
baseline TG.  Significant TG reductions (-13%) were noted in both groups 24 and 48 hours 
post-exercise.  Therefore, individuals exhibiting normal TG concentrations also have the 
ability to experience significant reductions after a single session of exercise.  As such, it 
would have been reasonable to expect the 90-minute exercise session employed in the current 
study to reduce TG concentrations in young, sedentary, overweight individuals. 
 When considering an accumulated effect of exercise, TG concentrations following 
three consecutive days of 90-minute exercise sessions resulted in a significant reduction 
when compared to the control period (Figure 7).  Therefore, the hypothesis stating that 
accumulating three sessions of exercise will produce improved TG concentrations compared 
to the control group is accepted.  However, it is important to note that the inter-treatment 
difference was due to a divergent response (i.e., TG decreased following the three-day 
exercise treatment, but increased over the control period).  Although a treatment-by-time 
effect was present, neither treatment by itself produced a statistically significant difference 
over time.  In addition, since no difference existed between the TG responses to one day 
versus three days of exercise (Figure 6), the hypothesis indicating that three consecutive days 
of exercise will produce greater improvements in TG concentrations compared to a single 
session of exercise is rejected. 
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 While the current study observed a significant percent change difference between the 
control and three exercise sessions, this difference is driven as much by the increase in TG 
during the control session than by the decrease following exercise.  Specifically, the control 
protocol showed an 18% increase while the three exercise sessions protocol elicited an 
average decrease of 17%.  While previous literature supports a 17% decrease in TG 
concentrations after an accumulated exercise protocol (Thompson et al., 2001; Durstine et al., 
2001), the increase in the control group was unexpected.  Since dietary variables were not 
significantly altered throughout the study it is possible that the increase in TG concentrations 
in the control group may reflect day-to-day variations.  While not statistically significant on 
its own (p=.06; Table 10), the decrease in TG concentrations after three exercise sessions 
indicates that TG was altered substantially by the accumulated sessions of exercise in some 
subjects.  However, the large standard error indicates a considerable variation of responses 
across subjects.  It is important to note that while the standard error was large, the average 
intra-assay coefficient of variation for this variable was small (2.4%). 
 Only a limited amount of literature exists regarding the accumulated effect of exercise 
on TG concentrations.  Angelopoulos et al. (1993) recruited young, sedentary, overweight 
males to perform three different exercise protocols; 1) a single session, 2) two sessions, with 
48 hours separation, and 3) three sessions, each with 48 hours separation.  All treadmill 
sessions were 30 minutes at 65% VO2max.  TG concentrations were not significantly altered 
during any exercise protocol 24 or 48 hours post-exercise.  Potential reasons for the non-
significant findings may be the shorter exercise duration or the longer amount of time 
between exercise sessions.  However, the current study was also unable to elicit statistically 
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significant TG changes when implementing a longer exercise duration and decreasing the 
time between sessions. 
 Two abstracts have reported significant post-exercise TG reductions following 
multiple sessions of exercise.  Four consecutive days of exercise at 70% VO2max (350 kcal, 
each separated by 24 hours) induced an additive effect of reduced TG concentrations in 
hyperlipidemic, middle-aged, obese men (Grandjean et al., 2001).  Baseline TG 
concentrations (266 mg/dL) were significantly reduced after the first exercise session and 
remained significantly lower after each successive session (i.e., separated by 24 hours), 
before reaching their nadir 24 (-80 mg/dL) and 72 hours (-75 mg/dL) after the fourth exercise 
session.  These findings suggest that accumulating successive sessions of exercise may elicit 
an additive effect beyond those observed after a single session of exercise in subjects with 
elevated TG concentrations.  In addition, the timing of these significant post-exercise 
reductions support the current study’s decreasing trend in TG concentrations through 24 
hours after the third exercise session (Table 10). 
 Another abstract reported the results from a three exercise session protocol, each 
session separated by 48 hours (Biggerstaff et al., 2005).  Young, sedentary, overweight 
women performed treadmill exercise for 500 kilocalories per session at 65% VO2max.  TG 
concentrations were significantly reduced 48 hours after the the last session of exercise.  
Specifically, these significant TG reductions (i.e., 20 mg/dL) were from a baseline of 103 
mg/dL.  The current study noted a 90 mg/dL baseline, with a 26 mg/dL reduction 24 hours 
post-exercise and 15 mg/dL reduction 48 hours post-exercise.  Therefore, while the current 
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study’s findings are not significantly different from baseline at p<0.05, the absolute TG 
reductions are comparable to the study above. 
 The decreasing TG concentration trend observed in the present study would not be 
possible if it were not for some individuals experiencing large absolute decreases.  Although 
past research shows TG concentrations to decrease independent of baseline concentrations, 
the current study showed subjects with elevated baseline concentrations to have the largest 
decreases following three consecutive days of 90 minutes of moderate-intensity exercise 
(Figure 8).  Interestingly, exercise training studies employing hypertriglyceridemic 
participants have consistently resulted in decreased TG concentrations, while results from 
studies employing normotriglyceridemic participants are inconsistent (Durstine & Haskell, 
1994).  Oddly, a non-significant increase was observed over the control protocol, but this 
trend, too, was dependent upon baseline concentrations (i.e., subjects with the lowest 
concentrations increased the most). 
 
TCHL and LDL-C Concentrations 
 
 Consistent with previous single-session (Angelopoulos et al., 1993; Davis et al., 
1992; Gordon et al., 1998; Grandjean et al., 2000; Hughes et al., 1990; Imamura et al., 2000; 
Park & Ransone, 2003; Tsetsonis & Hardman, 1995; Wooten et al., 2008)  and acute 
accumulated-session investigations (Angelopoulos et al., 1993; Grandjean et al., 2001), the 
current study did not result in a significant post-exercise TCHL concentration change during 
any protocol.  LDL-C concentrations were significantly decreased following the single 
exercise session (Figure 6) and the pre- versus post-exercise percentage change was 
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significantly different between the single exercise session and the three sessions of exercise 
protocol (Figure 7). 
 Most acute studies have not shown significant changes in LDL-C concentrations 
when controlling for various confounders (i.e., gender, dietary intake, baseline 
concentrations, plasma volume, body composition, etc.) (Angelopoulos et al., Bounds et al., 
2000; 1993; Davis et al., 1992; Gordon et al., 1998; Grandjean et al., 2000; Hughes et al., 
1990; Imamura et al., 2000; Kantor et al., 1987; Park & Ransone, 2003; Tsetsonis & 
Hardman, 1995; Wooten et al., 2008).  Moreover, studies utilizing subjects and an exercise 
duration comparable to the current study have not reported significant post-exercise LDL-C 
reductions (Bounds et al., 2000; Tsetsonis & Hardman, 1995).  Therefore, these studies 
suggest that a single extended session of exercise may not be sufficient to elicit significant 
LDL-C changes for young, sedentary individuals.  However, in support of the current study’s 
findings, a few studies have shown significant LDL-C reductions after a single session of 
exercise (Ferguson et al., 1998; Frey et al., 1993; Kantor et al., 1984).  These studies 
observed LDL-C reductions after well-trained males performed a moderate to high intensity 
extended session of exercise (i.e., 130 to 244 minutes or 1,500 kilocalories).  Although the 
exercise volume in these studies was abnormally high, it should be understood that the 
exercise volume employed in the current study was considerably high for untrained subjects.  
Therefore, while most acute exercise studies report no changes, LDL-C reductions may be 
observed after performing an extended session of exercise.  The exercise volume required to 
reduce LDL-C may depend upon baseline activity level. 
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 While one session of exercise produced a significant reduction in LDL-C, three 
consecutive sessions of exercise did not significantly alter LDL-C concentrations.  Most 
endurance exercise training studies have not reported LDL-C changes (Altena et al., 2006; 
Couillard et al., 2001; Halverstadt et al., 2003; Kraus et al., 2002; Leon et al., 2002; Leon et 
al., 2000; Leon et al., 1996; Nieman et al., 2002; Vislocky et al., 2009), however, nearly all 
studies estimate LDL-C concentrations (Friedwald et al., 1972) rather than measuring it 
directly.  Therefore, any error in measuring TCHL, HDL-C or TG concentrations will alter 
LDL-C estimation. 
Summary 
 
 The results of this study suggest that a single 90-minute session of moderate intensity 
aerobic exercise performed by young, sedentary individuals was not sufficient to elicit 
significant HDL-C or TG concentration changes.  However, three consecutive exercise 
sessions elicited a: 1) significant increase in post-exercise HDL-C concentrations, and 2) 
downward trend in post-exercise TG concentrations, mainly in those individuals with initially 
elevated concentrations.  Also, as previously demonstrated, the reponses for all measured 
variables were similar between men and women (Tsetsonis & Hardman, 1995) and black and 
white (Alhassan et al., 2001) participants. 
 A few underlying biochemical mechanisms for these aerobic exercise induced lipid 
and lipoprotein changes have been proposed.  It is hypothesized that aerobic exercise acutely 
depletes intramuscular triglycerides, stimulating the synthesis of lipoprotein lipase (LPL), 
facilitating the catabolism of triglyceride rich lipoproteins (i.e., chylomicrons and very low 
density lipoproteins) which leads to a reduction in plasma TG concentrations (Durstine & 
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Haskell, 1994).  Also, the catabolism of triglyceride-rich lipoproteins can result in the 
production of more remnants to be converted into HDL.  Since intramuscular triglyceride 
depletion can stimulate LPL activity, a greater depletion over the course of three days may 
have been a key factor in yielding larger HDL-C and TG changes.  Secondary to LPL 
activity, hepatic lipase (HL) activity has been shown to reduce or not change after aerobic 
activity, resulting in a prolonged survival time for HDL-C and, therefore, increased 
circulating HDL-C concentrations (Thompson et al., 2001).  While the primary exercise-
induced increases in HDL-C are attributed to changes in plasma lipase activities, a decrease 
in cholesteryl ester transport protein (CETP) levels after aerobic exercise are viewed as a 
secondary factor for the increased HDL-C concentrations (Seip et al., 1993).  Rather than 
being transferred to VLDL and LDL, this would allow for more cholesterol to remain within 
HDL-C.  While the current study did not assess these enzymatic processes, it appears that 
three sessions of exercise was sufficient to beneficially augment LPL, HL, and/or CETP 
activity. 
 Past discussion has suggested that blood lipid and lipoprotein concentrations can 
improve once a minimal exercise dose has been achieved (Haskell, 1994).  While this exact 
exercise dose has not been established, it is thought to be linked to the interaction between 
exercise intensity, frequency, and duration of each exercise session along with the length of 
the exercise training period.  The findings of this dissertation suggest that a threshold number 
of accumulated exercise sessions may exist for stimulating blood lipid and lipoprotein 
improvements.  In addition, this threshold may differ across various populations.  Specific to 
the current study, young, sedentary, overweight individuals performing three consecutive 
 
112 
 
 
prolonged sessions of moderate intensity exercise may experience HDL-C and TG 
improvements, beyond those observed after a single session of exercise. 
 In conclusion, in addition to two published abstracts (Grandjean et al., 2001; 
Biggerstaff et al., 2005), this study suggests that a beneficial additive exercise effect exists 
regarding HDL-C and, when elevated at baseline, TG concentrations.  While most exercise 
training studies have focused on the effects of intensity or overall volume of exercise, this 
“accumulated session” research provides an important beginning step in studying the effects 
of exercise frequency on plasma lipid and lipoprotein concentrations.  These results provide 
the justification for future exercise training studies to investigate a more exact manner in 
which exercise training frequency (e.g., every day, every other day, etc.) will enhance an 
individual’s lipid and lipoprotein profile.  While more research is necessary, the findings of 
this dissertation suggest that exercise on a daily basis may be most effective in improving 
HDL-C and TG concentrations.
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APPENDIX A 
 
RECRUITMENT FLYER 
SUBJECTS NEEDED FOR RESEARCH STUDY 
THE UNIVERSITY OF NORTH CAROLINA @ GREENSBORO 
DEPARTMENT OF EXERCISE AND SPORT SCIENCE 
 
The study protocol is investigating the effect of a single session of exercise versus 
accumulated sessions of exercise on blood lipid and lipoprotein concentrations. 
 
UNTRAINED/SEDENTARY SUBJECTS AGE 18-30 ARE NEEDED: 
 
You are eligible for participation if: 
• Over the past year you have exercised less than one day per week. 
• You are between 18 and 30 years of age. 
 
You are not eligible for participation if you: 
• Have a resting systolic blood pressure of 140 mmHg or greater. 
• Have a resting diastolic blood pressure of 90 mmHg or greater. 
• Use tobacco products. 
• Use illegal drugs. 
• Drink more than an average of 2 alcoholic beverages per day. 
• Have diabetes. 
• Are, or think you might be, pregnant. 
• Have been pregnant or have breastfed within the past six months. 
• Have a disease affecting the heart, kidneys, or any other major organ. 
• Have a muscle or bone condition that would affect your ability to walk/run on a 
treadmill. 
 
Benefits include: 
• FREE- Assessment of maximal aerobic capacity (VO2max). 
• FREE- blood lipid profile (i.e., measurement of total cholesterol, “good” and “bad” 
cholesterol, and triglyceride levels).  (Generally a $75 fee at a doctor’s office) 
• FREE- Body composition analysis (Generally a $100 fee at a health club). 
• FREE- Dietary analysis (Generally a $75 fee at a registered dietician). 
• Information regarding your current level of physical fitness. 
 
For more information, please contact: 
Jason Wagganer      
(336)272-7102 ex.468     
jwagganer@greensborocollege.edu     
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APPENDIX B 
DETERMINATION OF SAMPLE SIZE 
This study will utilize a repeated measures (12 levels) design.  It is expected that 90 
minutes of physical activity will elicit HDL-C and TG concentration changes from pre- to 
post-exercise.  These concentration changes will only be observed at certain time points (i.e., 
repeated measurements) during testing.  Therefore, in order to determine proper sample size 
a correlation between the time points of emphasis is required.  Since this correlation can only 
be determined from final data, an estimated correlation must be utilized for pre-study sample 
size determination.  Therefore, the following effect size calculations are based upon a 
moderate correlation of 0.70: 
 
Small effect size  =  f2 x m  =  0.01 x 12  =  0.12  =  0.4 
            1- p   1 – 0.70         0.3 
 
Moderate effect size =  f2 x m  =  0.0625 x 12  =  0.75  =  2.5 
               1 – p          1 – 0.70         0.3  
 
Large effect size  =  f2 x m  =  0.16 x 12  =  0.1.92  =  6.4 
           1 – p    1 – 0.70         0.3 
 
Calculations of degrees of freedom are based upon the following equations: 
 
dfeffect = 2 x (m-1) 
 
dferror = n x (m-1) 
Power calculations using G-power (statistical software) are as follows: 
 
 
 
n 
m        
(# rep. 
meas.) 
rho 
(corr.) f-squared 
adj. f-squared 
effect size 
df 
effect df error Power 
9 12 0.7 0.0625 2.5 22 99 0.7317 
10 12 0.7 0.0625 2.5 22 110 0.7977 
11 12 0.7 0.0625 2.5 22 121 0.8512 
12 12 0.7 0.0625 2.5 22 132 0.8929 
13 12 0.7 0.0625 2.5 22 143 0.9246 
14 12 0.7 0.0625 2.5 22 154 0.9479 
 
129 
 
 
APPENDIX C 
HEALTH HISTORY QUESTIONNAIRE 
Health History Questionnaire 
All of the information below is necessary to 1) insure your safety as a participant in this 
study, 2) to determine if you meet the qualification guidelines of this study, and/or 3) for the 
reporting of the demographics of this study.  Please answer all questions accurately.  If you 
are unsure as to how to answer any question, please notify the investigator.  All information 
on this form will be kept confidential. 
 
Name __________________________________________ 
 
Age__________   Birth Date________________________ 
 
Emergency contact:  Name______________________________________ 
 
Phone # (____)_________________ 
 
Please check the appropriate responses: 
1.  What is your race? 
     ______African American      ______Caucasian      ______Asian      ______Hispanic         
     ______Other (please list)_______________ 
 
2.  Do you currently use tobacco products: 
     ______Yes      ______No 
 
3.  If you answered “no” to Question #2, have you ever used tobacco products on a  
     regular basis in the past? 
     ______Yes      ______No 
 
4.  If you answered “yes” to Question #3, how long ago did you quit? 
     _________________________________________ 
 
5.  Have you ever been told that you have high blood pressure? 
     ______Yes      ______No 
 
     To the best of your knowledge, what is your blood pressure?__________________ 
 
6.  Have you ever been told by a doctor that you should not exercise or that you should  
     only exercise under medical supervision? 
     ______Yes      ______No 
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7.  Have you ever had problems with chest discomfort or dizziness? 
     ______Yes      ______No 
 
8.  Have you ever had a stroke or heart attack? 
     ______Yes      ______No 
 
9.  Are you diabetic? 
     ______Yes      ______No 
 
10. Are you, or do you think you might be, pregnant? 
     ______Yes      ______No 
 
11. Do you have any bleeding disorders? 
     ______Yes      ______No 
 
12. How many days per week do you exercise? 
 
13. In what type(s) of exercise do you participate? 
 
 
14. What is the average amount of time you spend participating in each activity? 
 
 
15. Do your answers to Questions 12-14 represent your exercise habits for at least the  
      past six months? 
      ______Yes      ______No 
 
16. Please list all prescribed and/or over-the-counter medications (including birth  
      control), nutritional supplements, and vitamins that you take on a regular basis. 
 
 
 
 
 
 
I have answered all the above questions truthfully to the best of my ability. 
 
Signature of Participant___________________________________________ 
 
Date__________________________________ 
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APPENDIX D 
PHYSICAL ACTIVITY QUESTIONNAIRE 
1.  For the last twelve months, which of the following moderate or vigorous activities  
     have you performed regularly?  (Please circle YES for all that apply and NO if you  
     do not perform the activity; provide an estimate of the amount of activity for all  
     marked YES.  Be as complete as possible). 
 
Walking 
NO YES  → How many sessions per week?  ________ 
   How many miles (or fractions) per session? ________ 
   Average duration per session?  ________ (minutes) 
 
 What is your usual pace of walking?  (Please circle one) 
 
 CASUAL or  AVERAGE or  FAIRLY          BRISK or 
 STROLLING  NORMAL  BRISK          STRIDING 
 (< 2 mph)  (2 to 3 mph)  (3 to 4 mph)          (4 mph or faster) 
 
Stair Climbing 
NO YES → How many flights of stairs do you climb UP each day? _________ 
   (1 flight = 10 steps) 
 
Jogging or Running 
NO YES → How many sessions per week?  ________ 
   How many miles (or fractions) per session? ________ 
   Average duration per session?  ________ (minutes) 
 
Treadmill 
NO YES → How many sessions per week?  ________ 
   How many miles (or fractions) per session? ________ (minutes) 
   Speed? _____ (mph) Grade? _____ (%) 
 
Bicycling 
NO YES → How many sessions per week?  ________ 
   How many miles per session?  ________ 
   Average duration per session?  ________ (minutes) 
 
Swimming Laps  → How many sessions per week?  ________ 
NO YES  How many miles per session? 
     (880 yds = 0.5 miles)   ________ 
   Average duration per session?  ________ (minutes) 
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Aerobic Dance/Calisthenics/Floor Exercise 
NO YES → How many sessions per week?  ________ 
   Average duration per session?  ________ (minutes) 
 
Moderate Sports 
(e.g. Leisure volleyball, golf (not riding), social dancing, doubles tennis) 
NO YES → How many sessions per week?  ________ 
   Average duration per session?  ________ (minutes) 
 
 
Vigorous Racquet Sports 
(e.g. Racquetball, singles tennis) 
NO YES → How many sessions per week?  ________ 
   Average duration per session?  ________ (minutes) 
 
Other Vigorous Sports or Exercise Involving Running 
(e.g., Basketball, soccer) 
NO YES → Please specify:________________________________ 
   How many sessions per week?  ________ 
   Average duration per session?  ________ (minutes) 
 
Other Activities 
NO YES → Please specify:________________________________ 
   How many sessions per week?  ________ 
   Average duration per session?  ________ (minutes) 
 
Weight Training 
(Machines, free weights) 
NO YES → How many sessions per week?  ________ 
   Average duration per session?  ________ (minutes) 
 
Household Activities (i.e., Sweeping, vacuuming, washing clothes, scrubbing floors) 
NO YES → How many hours per week?   ________ 
 
Lawn Work and Gardening 
NO YES → How many hours per week?   ________ 
 
 
2.  How many times a week do you engage in vigorous physical activity long enough to  
     work up a sweat? ________ (times per week) 
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APPENDIX E 
INFORMED CONSENT FORM 
The University of North Carolina at Greensboro 
CONSENT TO ACT AS A HUMAN SUBJECT: LONG FORM 
 
Project Title:  Effect of Exercise Accumulation on Plasma Lipids 
  
Project Director:  Jason D. Wagganer 
 
Participant’s Name:  __________________________________________________ 
 
Date of Consent:  _____________________________________________________ 
 
Description and Explanation of Procedures: 
This study is designed to compare single session to accumulated sessions of exercise on 
blood cholesterol levels.  As a participant, you will need to report to UNCG’s Exercise and 
Sport Science Department’s Exercise Physiology Laboratory for all testing procedures:  
Protocol One: four visits, Protocol Two: six visits, Protocol Three: two visits; each protocol 
separated by at least one week and each visit separated by 24 hours. 
 
• Blood collection:  Blood (28mL, approximately 2 tablespoons) will be collected at the 
beginning of each laboratory visit by a blood collection specialist (e.g., phlebotomist).  
Blood will be analyzed for concentrations of total cholesterol, HDL- and LDL- 
cholesterol, and triglyceride.  Experimental exercise protocols will be timed based 
upon initiation of menstrual cycle for female participants.  Blood collection for all 
female participants will occur between the first and tenth day of your menstrual cycle.  
Male participants will have blood collected prior to laboratory visits involving 
exercise. 
• Graded exercise test visit:  Prior to exercise testing, resting blood pressure, heart rate, 
and body fat percentage will be conducted.  Blood pressure and heart rate readings 
will be conducted after a 10-minute rest period in a quiet environment.  Body fat 
percentage will be estimated from a three-site skinfold technique.  Waist 
circumference will also be measured.  Maximal oxygen consumption (VO2max), a 
measure of physical fitness, will then be measured during a graded exercise test on a 
motorized treadmill.  For your safety the electrical activity of your heart will be 
monitored during the VO2max test.   The exercise protocol will start at a moderate 
walk/run pace, with intensity increasing every two minutes until you can no longer 
continue.  It is important for you to give a maximal effort during this test.  However, 
if you feel anything unusual at any time, you should inform the researcher 
immediately and, if necessary, the test will be terminated.  You also have the right to 
terminate any procedure of this experiment at any time.  This session will last 
approximately one hour. 
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• Experimental Exercise Protocols:  Protocol One will require you to complete a 90-
minute treadmill exercise session at a moderate (60% VO2max) pace, followed by three 
visits (each separated by 24 hours) for fasted blood draws.  Protocol Two will require 
you to complete three 90-minute treadmill exercise sessions at a moderate (60% 
VO2max) pace.  After completion of the third exercise session, three more visits will be 
required for fasted blood sampling (each separated by 24 hours).  Protocol Three will 
require two laboratory visits over a six day period.  You will report to the lab on day 
one and day six for fasted blood draws. 
 
To participate in this study, you must: 
• Be 18-30 years of age 
• Be obese based upon waist circumference and body weight.  The criteria for waist 
circumference and weight depend on sex and height, respectively. 
• Exercise less than one time per week over the past six months 
 
You are not eligible for participation if you: 
• Have a resting systolic blood pressure of 140mm Hg or greater 
• Have a resting diastolic blood pressure of 90mm Hg or greater 
• Use tobacco products 
• Use illegal drugs 
• Drink more than 2 alcoholic beverages per day 
• Have diabetes 
• Are, or think you might be, pregnant 
• Have a disease affecting the heart, kidneys, or any other major organ 
• Have a muscle or bone condition that would affect your ability to walk/run on a 
treadmill 
 
Risks and Discomforts: 
A very slight chance of heart attack and even death exists during exercise.  The chance of 
such an incident will be minimized by pre-screening and maintaining a proper emergency 
protocol to include, if needed, cardiopulmonary resuscitation (CPR) and notification of the 
Emergency Medical Service (EMS).  In addition, there is a slight possibility that you will feel 
weak or faint from fasting.  You should tell the researcher if you experience any unusual 
sensations before, during, or after any exercise tests.  Since you do not have known heart, 
lung, or metabolic disease, or smoke, and do not have severely high blood pressure, the 
potential benefit of participation most likely outweighs the risks.  In addition, a chance of 
bruising and a very slight chance of infection exists with all blood collection procedures.  
This will be minimized through use of a trained phlebotomist and sterile materials. 
 
Potential Benefits: 
For no charge, each participant will receive information concerning cardiorespiratory fitness, 
body composition, blood pressure, and blood cholesterol levels relating to risk of 
cardiovascular disease (CVD).  Data from this study will be used to define optimal exercise 
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frequency for individuals at risk for CVD. You will be paid $100.00 upon completion of all 
required laboratory visits.  The entire experiment must be completed in order to receive this 
payment. 
 
Consent: 
By signing this consent form, you agree that you understand the procedure and any risks and 
benefits involved in this research.  You are free to refuse to participate or to withdraw your 
consent to participate in this research at any time without penalty or prejudice; your 
participation is entirely voluntary.  Your privacy will be protected because you will not be 
identified by name as a participant in this project.  Only members of the research team will 
have access to your records unless you give written permission for your information to be 
given to someone else.  Data from this experiment will be kept in a locked filing cabinet for 
at least five years after the study’s completion and will then be disposed of by paper 
shredding.  Your blood may need to be tested for evidence of hepatitis, HIV, or other 
infections in the event anyone involved in the study is exposed to your blood. 
 
The research and this consent from have been approved by the University of North Carolina 
at Greensboro Institutional Review Board, which insures that research involving people 
follows federal regulations.  Questions regarding your rights as a participant in this project 
can be answered by calling Mr. Eric Allen at (336) 256-1482.  Questions regarding the 
research itself will be answered by Jason D. Wagganer by calling (336) 686-7825.  Any new 
information that develops during this project will be provided to you if the information might 
affect your willingness to continue participation in the project. 
 
By signing this form, you are agreeing to participate in the project described to you by 
 
__________________________________________ (investigator). 
 
 
___________________________________ 
Participant’s Signature 
 
___________________________________ 
Witness to Signature 
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APPENDIX F 
MEDICAL RELEASE FORM 
To the attending physician of ________________________________ 
 
Your patient has expressed interest in participating in our study entitled, “Effects of Exercise 
Accumulation on Plasma Lipids and Lipoproteins”.  This study is designed to compare the 
effects a single session of exercise to the accumulation of exercise sessions in young 
sedentary and obese individuals.  Factors to be measured include maximal oxygen 
consumption (VO2max), blood pressure, body composition, and plasma concentrations of total 
cholesterol, LDL, HDL, and triglycerides.  Because many subjects may possess 
cardiovascular risk factors, as well as being sedentary and obese, we are requiring all study 
participants to obtain their physician’s approval before participation.  Please read the study 
description below and sign the release form if, in your medical judgment, this individual 
shows no contraindication to study participation. 
 
Inclusion Criteria: 
* Be 18-30 years of age 
* Be obese based upon waist circumference and body mass index: 
- Waist circumference >102 cm for men, >88 cm for women. 
- Body mass index of 25-35 kg/m2 
* Have performed less than one day per week of physical activity during the previous  
 six months. 
 
Exclusion Criteria: 
* Resting systolic blood pressure of 140 mm Hg or greater 
* Resting diastolic blood pressure of 90 mm Hg or greater 
* Use of tobacco products 
* Use of illegal drugs 
* Average consumption of more than 2 alcoholic beverages per day 
* Diabetes 
* Known or suspected pregnancy 
* Have been pregnant or have breastfed within the past six months 
* Disease affecting the heart, kidneys, or any other major organ 
* Any muscle or bone condition that would affect the ability to walk/run on a treadmill 
 
Study Protocol: 
This study is designed to compare single session to accumulated sessions of exercise on post-
exercise plasma lipid and lipoprotein concentrations.  Participants will report to UNCG’s 
Exercise and Sport Science Department’s Exercise Physiology Laboratory for all testing 
procedures:  Protocol One: four visits, Protocol Two: six visits, Protocol Three: two visits; 
each protocol separated by one month and each visit separated by 24 hours. 
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• Blood collection:  Blood (28mL, approximately 2 tablespoons) will be collected at the 
beginning of each laboratory visit by a trained phlebotomist.  Experimental Protocol 
1 will require 112mL, Protocol 2 will require 168mL, and Protocol 3 will require 
56mL, totaling 336mL of blood for all three experimental protocols (e.g., spanning a 
three month time period).  Experimental exercise protocols will be timed based upon 
initiation of menstrual cycle for female participants.  Blood collection for all female 
participants will occur between the first and tenth day of your menstrual cycle.  Male 
participants will have blood collected in the same pattern as female participants, with 
one month in between each exercise protocol. 
• Graded exercise test visit:  Prior to exercise testing, participants will undergo testing 
for resting blood pressure, heart rate, and body fat percentage.  Blood pressure and 
heart rate readings will be conducted after a 15-minute rest period in a quiet 
environment.  Body fat percentage will be estimated from skinfold measurements.  
Waist circumference will also be measured.  Maximal oxygen consumption (VO2max) 
will then be measured while exercising to fatigue during a graded exercise test on a 
motorized treadmill.  During this test, an ECG will be used for measurement of heart 
rate.  The exercise protocol will start at a moderate walk/run pace, with intensity 
increasing by 2.5% (primarily by grade increases) every two minutes until the 
participant can no longer perform the exercise.  It is important for each participant to 
give a maximal effort during this test.  In addition to these requirements, criteria for 
the attainment of VO2max will include heart rate within 10 beats/minute of age 
predicted maximum (220-age), respiratory exchange ratio >1.1, and oxygen 
consumption plateau despite increased work rate. 
• Experimental Exercise Protocols:  Protocol One will require four visits to the exercise 
physiology laboratory, each visit separated by 24 hours.  The first visit will require 
participants to complete a 90-minute treadmill exercise session at a moderate (60% 
VO2max) pace, followed by three visits (each separated by 24 hours) for fasted blood 
sampling.  Protocol Two will require six visits to the exercise physiology laboratory, 
each visit separated by 24 hours.  The first three visits to the lab will require blood 
samples prior to a 90-minute treadmill exercise session at a moderate pace 
(60%VO2max).  After completion of the third exercise session, three more visits will 
be required for fasted blood sampling.  Protocol Three will require two laboratory 
visits over a six day period.  Participants will report to the lab on day one and day six 
for fasted blood sampling. 
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Data from this study will be used to identify the optimal exercise frequency related research 
in young overweight and obese individuals at risk for CVD.  These studies will also provide 
baseline information for future research involving exercise frequency in different age groups 
and CVD risk profile.  If further information is needed, or there are further questions 
regarding the experimental protocol, please feel free to contact the principal investigator/co-
investigator: 
 
Jason D. Wagganer, MS    Paul G. Davis, PhD 
Dept. of Kinesiology     Dept. of Exercise and Sport Science 
Greensboro College     UNCG 
(336) 272-7102 ex.468    (336) 334-3030  
jwagganer@greeensborocollege.edu   pgdavis@uncg.edu 
 
Thank you for taking the time to consider your patient’s participation in this study. 
 
Release 
 
I believe my patient to be capable of safely participating in the investigation, “Effects of 
Exercise Accumulation of Plasma Lipids and Lipoproteins”, as described above. 
 
Signature__________________________  Print Name_________________________ 
Date____________________________ 
Adress_______________________________________________________________ 
_____________________________________________________________________ 
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APPENDIX G 
 
SUBJECT DATA FORM 
Subject’s Name ____________________ Age: _______ Date:_______________ 
Date menstrual cycle began____________  Fasted? (check if “yes”) _____________ 
           Average 
Waist Circumference ________ ________ ________  ________ 
Resting BP: 
Left Arm  ____/___ ____/___ ____/___ 
Right Arm  ____/___ ____/___ ____/___ 
Resting HR: 
Left Arm  ________ ________ ________ 
Right Arm  ________ ________ ________ 
Male Skinfolds: 
Chest   ________ ________ ________  ________ 
Abdominal  ________ ________ ________  ________ 
Thigh   ________ ________ ________  ________ 
Female Skinfolds: 
Tricep   ________ ________ ________  ________ 
Suprailiac  ________ ________ ________  ________ 
Thigh   ________ ________ ________  ________ 
         Total: ________ 
% Body Fat:  ________ 
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APPENDIX H 
RATING OF PERCEIVED EXERTION SCALE 
     Category Scale      
6 
 
7  Very, Very Light 
 
8 
 
9  Very Light 
 
          10 
 
11 Fairly Light 
  
12 
 
13 Somewhat Hard 
 
14  
 
15 Hard 
 
16   
 
17 Very Hard 
 
18 
 
19  Very, Very Hard 
 
20  
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APPENDIX I 
STUDY PROCEDURES (PRE-STUDY SCREENING) 
1. Assess waist circumference (men >102cm; women > 88cm) and verify previous  
 sedentary lifestyle (i.e., less than one exercise session per week for the past six  
 months). 
2. During a 10-minute resting period have subject complete physical activity  
 questionnaire, health history questionnaire, and informed consent. 
3. Conduct BP and HR measurements. 
4. Conduct resting 12-lead EKG for 5 minutes. 
5. Schedule physical with health center. 
6. Fully describe future scheduling dates and exercise protocols. 
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APPENDIX J 
STUDY PROCEDURES (MAXIMAL EXERCISE VISIT) 
1. Have subject rest in a seated position for 10 minutes, then obtain HR and BP. 
2. Obtain height, weight, and skinfolds (% fat, fat mass and LBM with program on lab 
computer). 
3. VO2max test on treadmill (have metabolic cart calibrated and ECG prep materials ready).  
While prepping subject for ECG, explain RPE scale and test procedures.  Allow subject 
to drink prior to fitting mouthpiece and conducting warm-up. 
4. Get treadmill speed to subject selected RPE between 10-12.  Begin test (2-min stages).  
Increase speed 0.5 mph until 75% predicted HRmax is reached.  Increase grade 2.5% 
every stage thereafter until volitional exhaustion. 
5. After completion of max test, transfer vital data to the 60% VO2max data form. 
6. Give subject instructions – maintain regular sedentary lifestyle throughout the entire 
study, complete food diary records the three days prior to the first visit of each 
experimental protocol and then daily records for each experimental session. 
7. Schedule subjects for all experimental sessions (give randomization).  Have full  
 copies of calendars indicating exact dates and times of future sessions. 
8. Call each subject prior to each test day (starting with the three days preceding each  
 test day for dietary compliance) to remind subject of proper participation. 
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APPENDIX K 
 
VO2max TEST DATA FORM 
NAME:_______________________  AGE:_________ DATE:____________ 
 
Minute Speed Grade 
Heart 
Rate BP RPE VO2 Comments 
1    
  
  
2      
3    
  
  
4      
5    
  
  
6      
7    
  
  
8      
9    
  
  
10      
11    
  
  
12      
13    
  
  
14      
 
Termination time:_____________ Max HR:________     Max VO2:__________ 
Reason for Termination: 
 
144 
 
 
APPENDIX L                                  Session:________ 
60% VO2max DATA FORM                            Trial:________ 
NAME:_______________________  AGE:_________ DATE:____________ 
VO2max:________     60% VO2max:_______ HRmax:________       60% HRmax:_________ 
Min. Speed Grade Heart Rate Kcal Output RPE VO2 mL/min Mouthpiece 
1         
2         
3         
4         
5         
6         
7         
8         
9         
10         
11         
12         
13         
14         
15         
20         
25         
30         
35         
40         
45         
50         
55         
60         
65         
70         
75         
80         
85         
90         
 
Total kcal expended:________       Avg. HR:________   Avg. % HRmax:__________      
Avg. VO2:________        Avg. % VO2 max:__________ 
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APPENDIX M 
STUDY PROCEDURES (EXPERIMENTAL EXERCISE SESSIONS) 
1.  Know at what workload and heart rate subject achieved 60% VO2max; prep cart. 
2.  Obtain subject’s current weight, then have them sit for 10 minutes; obtain RBP/RHR.   
     Take blood sample and perform plasma volume test, spin down blood (1500 rpm x 20  
     minutes).  Have subject drink water and loosen up during this time. 
3.  Put on heart rate monitor, fit mouthpiece and noseclip, conduct a brief warm-up. 
4.  Start 60%VO2max treadmill exercise (put mask on at 5:00 and begin acquiring gas  
     exchange data at 7:00). 
5.  Acquire gas exchange until 23:00 minutes. 
6.  After the first gas exchange reading, remove mouthpiece; monitor HR during next 15  
     minutes (36:00 minute).  If necessary, allow subject to rest in a seated position for five 
 minutes.  Allow subject to drink water (i.e., 4 mL/kg) during this rest period. 
7.  If no rest is required, replace mouthpiece and begin calculating caloric expenditure at  
 38:00 minutes. 
8.  At 55:00 minute mark remove mask and continue exercising until 75:00 minute mark,  
     at which time another five minute rest period (if necessary) will be conducted (same as  
 above). 
9. At the 75:00 minute mark, begin exercise; replace mouthpiece and begin calculating  
    caloric expenditure based upon VO2, until 90:00 minute mark. 
10. End test and print-out VO2 data sheet (multiply all VO2 numbers by 1.13) (Cool-down) 
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APPENDIX N 
FOOD DIARY DATA FORM 
Please list ALL food and drink consumed during the three days before the first day of each 
experimental session, in addition to each experimental day.  Use a separate sheet for each day 
and refer to the following examples for ideas on how specific you should be. 
7:00am Eggs (fried) 2 whole (jumbo) 180 
    4 whites (jumbo) 75 
  wheat bread 3 slices 200 
  jelly (grape) 3 tsp. ? 
  orange juice (conc.) 2 cups 200 
11:00am Rice (instant/white) 1 cup (dry) 300 
  baked chicken 8 oz. 300 
  (boneless/white meat)    
  olive oil 2 tbs. 240 
 
Time Food Source 
Quantity 
(oz./cups) 
Calories (if 
known) 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
 
Name:     Day:     Date:    
